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The anterior cruciate ligament (ACL) is the most commonly injured ligament of the knee with 
well over 200,000 injuries in the US annually.  Surgical reconstruction is a widely used treatment 
option that involves replacing the ACL with a soft tissue graft.  ACL reconstruction is often 
associated with problems such as pain and long-term follow-up studies have shown that up to 
25% of patients have experienced unsatisfactory results that include prevalence of osteoarthritis. 
In recent years, there has been a renewed interest in regenerating the ACL as an 
alternative treatment option.  In our research center, an innovative approach was developed using 
an extracellular matrix (ECM) sheet and hydrogel along with a novel metallic implant made of 
magnesium (Mg) designed to connect the two ends of a torn ACL.  The biological augmentation 
provided by the ECM scaffolds has been shown to incite and accelerate new tissue growth.  The 
mechanical augmentation provided by the Mg ring can restore stability to the knee immediately 
post-operatively and load the healing ligament throughout the healing process preventing disuse 
atrophy of the insertion sites.  Additionally, the repair construct can be resorbed by the body as 
the healing tissue begins to bear load. 
The objective of this research was to continue the development of ECM + Mg ring repair.  
First, single crystal Mg was coated using micro-arc oxidation to engineer a degradation rate 
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 v 
appropriate for the ACL healing application and the corrosion, coating, and surface properties of 
this novel material-coating combination were characterized.  Then, a long-term study of ECM + 
Mg ring repair of a surgically transected ACL in a goat model was performed to examine if the 
advantages persist up to 26 weeks.  The joint stability, ligament function and structural properties 
of the femur-ACL-tibia complex were measured.  Finally, the Mg ring was redesigned for the 
human ACL and evaluated using finite element analysis and in human cadaveric knees. 
This dissertation research has found exciting results that a goat ACL can heal 
successfully with a combined biological and mechanical augmentation approach and suggests 
further study of ACL healing in humans.  In the end, such an approach could lead to an 
alternative treatment for ACL injuries. 
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“So teach us to number our days, that we may apply our hearts unto wisdom.”  
Psalm 90:12 
 
In 2011, Dr. Harvey Borovetz, chair of the Department of Bioengineering at the University of 
Pittsburgh (Pitt) at the time, was visiting North Carolina A&T State University (NCAT) in 
Greensboro, NC where I was a student of their newly established Bioengineering graduate 
program.  My professor, Dr. Devdas Pai, asked Dr. Borovetz if he knew of a summer research 
opportunity at Pitt in which I could participate.  Dr. Borovetz said he would reach out to some 
labs.  After a short time, we received notice that Dr. Savio L-Y. Woo of the world renowned 
Musculoskeletal Research Center (MSRC) had a vacancy for a summer research internship.  At 
that time, I could have never imagined the unique opportunity that lay ahead would blossom into 
two summers of research while I completed my masters at NCAT and another four and a half 
years of doctoral studies under the support and mentorship of Dr. Woo.  Throughout my graduate 
career at Pitt, there have been so many people who have contributed to my work and I would like 
to formally acknowledge them.  
First, I would like to thank Dr. Woo.  Thank you for accepting me as a summer student 
back in 2011 and 2012 and as a doctoral student in 2013 even after you weren’t accepting any 
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more student.  It’s an indescribable honor to be the last student of your career.  You have shaped 
my thinking and practice as a researcher and engineer.  Your philosophy will forever inspire me 
to achieve higher and be better in everything that I do. 
My experience at Pitt has been like none other because of the family I have formed with 
the staff and students of the MSRC. To previous graduate students, Dr. Kwang Kim and Dr. 
Katie Farraro; orthopaedic surgery fellows, Matteo Tei, Andrea Speziali, Norihiro Sasaki, 
Antonio Pastrone, Chris Chiang, and Huijun Kang; predoctoral fellow Huizhi Wang; 
undergraduate research students, Kit-Yu Leung, Sara Orr, Dhir Patwa, Seth Cordts, Lindsay 
Hess, Lewis Gross, Chak Yuk Yu, Sean Mackey, Yajnesh Vedanaparti, and Ian Moran; and 
executive assistant and friend Diann DeCenzo: I appreciate you all and the work we have done 
together. 
There have been many collaborators who have taught me so much about what it means to 
be a part of a multi-disciplinary team.  I would like to thank Dr. Steven Abramowitch (Dr. Bill 
Barone, Dr. Katrina Knight, Deanna Easley), Dr. Prashant Kumta (Dr. Abhijit Roy, Dr. Da-Tren 
Chou, Jingyao Wu, John Ohodnicki), Dr. Stephen Badylak (Scott Johnson, Jenna Dziki, 
Madeline Cramer), Dr. Patrick McMahon, Andy Holmes of the Swanson Center for Product 
Innovation, Dr. Bob Wagner and the Division of Laboratory Animal Resources staff, and 
NATON Medical Group. I would like to acknowledge the support of Dr. Harvey Borovetz, Dr. 
Sanjeev Shroff and the Department of Bioengineering, Dr. Sylvanus Wosu and the Department 
of Diversity, Dr. Jaganathan Sankar, Dr. William Wagner, Dr. Matthew McCullough, Dr. 
Devdas Pai, Dr. Yeoheung Yun, Dr. Vesselin Shanov and the NSF Engineering Research Center 
for Revolutionizing Metallic Biomaterials (ERC-RMB), Max Fedor and Suneera Bhatia and the 
Coulter Translational Research Partners II Program, the Biomechanics in Regenerative Medicine 
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(BiRM) training program, and Dr. Paul Monga and the Cellular Approaches to Tissue 
Engineering and Regeneration (CATER) training program. 
Finally, I must thank my friends and family.  I appreciate my longtime friends in Atlanta 
and my new friends in Pittsburgh.  The Hillcrest SDA Church has been an amazing support 
system.  My biggest motivators and cheerleaders have been my mother, Phyllis Haskins, and my 
husband, Edwin Mau.  Thank you!   
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1.0  MOTIVATION 
The anterior cruciate ligament (ACL) is a major stabilizer of the knee, aiding in the control of the 
6 degrees of freedom (DOF) of knee motion [1, 2].  It is the most often injured knee ligament 
with well over 200,000 injuries in the United States per year and associated costs exceeding $2 
billion [3, 4].  ACL injures commonly occur during sporting and work related activities and can 
lead to functional instability and long-term complications such as meniscal injuries, failure of 
secondary stabilizers, and the early onset of osteoarthritis [5]. 
There are several treatment options for ACL injuries including conservative (nonsurgical) 
treatment and surgical reconstruction.  Nonsurgical therapy includes bracing and rehabilitation 
protocols that aim to regain joint mobility and improve neuromuscular function to obtain 
compensatory functional stability [6, 7].  The most common treatment is ACL reconstruction 
(ACLR) and is selected for nearly two-thirds of all ACL injury patients.  ACLR is an 
arthroscopic procedure where the injured ACL is removed and replaced with a soft tissue graft.  
While ACLR is able to restore joint stability in the short-term, there are consistent reports of 
unsatisfactory outcomes in the long-term including problems with pain, especially at the graft 
donor site.  Also, long-term follow-up studies have shown that 20% to 25% of patients have an 
increased risk in developing osteoarthritis [8-11].  Additionally, there are over 9,000 scientific 
journal articles on ACLR aiming to make improvements to various components of the surgical 
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procedure, suggesting that an ideal surgical procedure yielding good short- and long-term 
outcomes has yet to be developed. 
An advantageous alternative to ACLR is to heal the native ACL.  This approach to 
treating ACL injuries would have many advantages over ACLR, including preservation of its 
complex anatomy, insertion sites, proprioceptive nerve fibers, and biomechanical properties.  
Patients could also avoid the problems associated with donor site morbidity seen with ACLR 
because healing the ACL would eliminate the need for graft harvesting and large bone tunnels in 
the femur and tibia.  However, the ACL has a limited potential for healing, even in the case of 
incomplete rupture [12].  For this reason, suture repair, a surgical technique that attempts to 
reconnect the torn ends of the ACL to permit healing, has been an inferior option demonstrating 
no difference to conservative treatment [13-15]. 
With recent advances in tissue engineering, there has been a renewed interest in ACL 
healing.  Previous ACL healing studies have focused their efforts on biological strategies such as 
mesenchymal stem cells [16], growth factors [17], platelet-rich plasma [18], and extracellular 
matrix (ECM) bioscaffolds [19].  The results of these studies have demonstrated an ability to 
increase new tissue growth but do not successfully restore the joint stability and biomechanical 
properties of the normal ACL suggesting that biological augmentation alone is not sufficient [18, 
19].  This knowledge has been the motivation for our innovative approach to ACL healing called 
“ECM + Mg-ring repair” which combines biological augmentation and mechanical augmentation 
using ECM scaffolds and a resorbable metallic implant.  The feasibility of ECM + Mg-ring 
repair has been demonstrated at time zero and in short-term preclinical studies [20, 21].  This 
approach has been shown to both accelerate new tissue growth and restore joint stability [20, 21].  
With such promising results, it is evident that ACL healing is still a promising treatment option.  
3 
Thus, the overall objective of this dissertation research was to characterize the Mg material used 
for the implant, complete a long-term study of ECM + Mg-ring repair of a transected ACL in a 
goat model and use the acquired knowledge to further develop the Mg-ring device for human 
application.  
4 
2.0  BACKGROUND 
2.1 BIOLOGY AND BIOMECHANICS OF LIGAMENTS  
Ligaments are bands of soft connective tissues composed of closely packed, parallel collagen 
fiber bundles that connect bone to bone.  These unique tissues serve essential roles in the 
musculoskeletal system by transferring tensile loads to maintain stability and guide motion of 
diarthrodial joints.  Knowledge of the biology and biomechanics of ligaments provide insight to 
how ligaments function in response to physiological and pathological loading. 
2.1.1 Biochemical Composition and Histological Structure 
Ligaments have low vascularity and low cellularity with less than 5% of the total volume 
occupied by cells [22-25].  The cells in these tissues are called fibroblasts and function to 
maintain and remodel the extracellular matrix (ECM) in which they reside.  Ligaments consist of 
both the fibrillar components including collagen and elastin and the nonfibrillar components such 
as proteoglycans, glycolipids, and water (65% to 70% of total weight).  The collagen fibers are 
organized and well-oriented along the longitudinal direction with fibroblasts arranged in rows 
along the fibers [26, 27]. 
Approximately 70% to 80% of the dry weight of normal ligament is composed of type I 
collagen.  Histologically, collagen fibers display a regular wavy appearance, or crimp pattern, 
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under unloaded conditions [23, 25, 28, 29].  Under transmission electron microscopy, a bimodal 
distribution of collagen fibril size can be observed with a smaller group of fibrils measuring 
between 40 and 75 nm in diameter and the larger fibrils between 100 and 150 nm in diameter 
[30-33].  The smaller fibrils are located in the spaces between the larger fibrils allowing for 
optimal fibril packing [34].  This bimodal distribution is functionally significant because the 
incorporation of a high number of small diameter fibrils ensures better binding between fibers by 
virtue of their higher surface to volume ratio while the larger diameter fibrils provide the 
stiffness and strength requirements.  Collagen also has the ability to form covalent intramolecular 
and intermolecular crosslinks, which are key to its tensile strength characteristics and resistance 
to chemical or enzymatic breakdown [35-37]. 
There are many other collagen types, including III, V, IX, X, XI, and XII, present in 
much less amounts but still play important roles in maintaining the structure and function of 
ligaments.  For example, type III collagen is involved in tissue healing and remodeling [38] and 
type V collagen exists in association with type I collagen and serves as a regulator of collagen 
crosslinking and fibril diameter [39, 40].  Furthermore, type XII collagen provides lubrication 
between collagen fibers [41].  Collagen types IX, X, and XI exist with type II collagen at the 
fibrocartilaginous zone of the ligament-bone interface [42-44] and function to minimize the 
stress concentrations when loads are transmitted from soft tissue into bone [45, 46]. 
Elastin, which is present in ligaments in a few percent by weight, allows the tissue to 
return to its prestretched length following physiological loading.  The ground substance 
constituents of ligaments make up only a small percentage of the total dry tissue weight but are 
nevertheless quite significant because of their ability to imbibe water.  The water and 
proteoglycans provide lubrication and spacing that are crucial to the gliding function of fibers in 
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the tissue matrix.  Ligaments display time- and history-dependent viscoelastic properties that 
reflect the complex interactions between proteins, ground substance, and water    Collectively, 
these constituents serve to maintain fiber orientation and separation for optimal function [47]. 
At the ultrastructural level, ligaments have a hierarchal organization composed of fibrils, 
fibers, subfascicular units, fasciculi, and the tissue itself (Figure 1) [48].  Ligaments are 
surrounded by a loose areolar connective tissue, referred to as periligament [49, 50].  This 
ensheathment facilitates gliding movements of fibers allowing them to stretch and bend against 
each other and the parallel arrangements of fibers allows forces to be channeled in specific 
directions [48].   
 
 
Figure 1: A schematic of the structural hierarchy of ligament [51]  
 
Ligament insertions to bone distribute and dissipate forces by transmitting them through 
the fibrocartilage to bone.  There are two types of insertions: direct and indirect.  Direct 
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insertions are more common having four distinct phases in the transition from ligaments to bone: 
ligament, fibrocartilage, mineralized fibrocartilage, and bone [45, 52, 53].  The size of each zone 
varies with particular ligaments; however, the total length of the transition zone is usually much 
less than 1 mm.  Indirect insertions are more complex morphologically as there are distinct 
superficial and deep fibers.  The superficial fibers are connected to the periosteum, whereas the 
deeper fibers, called Sharpey fibers, are anchored directly to the bone [45, 53, 54].  Indirect 
insertions usually occur when the ligaments attach to bone after crossing the epiphyseal plate. 
2.1.2 Tensile Properties of Ligaments 
The primary functions of ligaments are to maintain the proper anatomic alignment of the 
skeleton and guide joint movements.  They also transmit forces along their longitudinal axis.  
Thus, their biomechanical properties are measured via uniaxial tensile testing to obtain structural 
and mechanical properties. 
2.1.2.1 Structural Properties of Bone-Ligament-Bone Complex 
 Uniaxial tensile testing of ligaments can be complex as there are many factors that have 
been shown to affect the outcome.  Isolated ligaments are difficult to test independently due to 
the short length of the ligament substance and the common problem of specimen slippage from 
clamps.  As a result, uniaxial tensile tests are generally performed using the entire bone-
ligament-bone complex (e.g. femur-ACL-tibia complex or FATC) with ligament insertion sites 
left anatomically intact.  The bones are clamped such that the ligament can be aligned to the 
applied tensile load.  Using a materials testing machine, a load is applied along the longitudinal 
axis of the ligament at a prescribed rate until failure.  A resulting load-elongation curve is 
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obtained (Figure 2).  Generally, the curve has a nonlinear toe region characteristic of the 
recruitment and uncrimping of collagen fibers, the linear region, and the failure region.  The 
parameters that describe the structural properties of the specimen include the ultimate load, the 
ultimate elongation, linear stiffness, and energy absorbed at failure.  The ultimate load is the 
maximal force applied to the specimen and the corresponding elongation is the ultimate 
elongation or elongation at failure.  The linear stiffness is the slope of the linear region and 
energy absorbed at failure is the area underneath the curve.  The parameters reflect behavior of 
the entire bone-ligament-bone complex which includes tissue geometry, orientation of collagen 
fibers to applied loads as well as the contribution of the bony insertions [55].   
 
 
Figure 2: A typical load-elongation curve from uniaxial tensile testing of a bone-ligament-bone 
complex representing its structural properties [56]  
 
Structural properties of a bone-ligament-bone complex are sensitive to testing conditions.  
Specimen orientation during tensile testing, for example, has been shown to significantly affect 
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the structural properties.  When human FATCs were tested in an anatomical orientation where 
the angles of insertion at the femur and tibia are preserved, stiffness and ultimate load of FATCs 
were significantly higher compared to those tested in a nonanatomical orientation where it was 
aligned along the tibial axis [57].  Specimen storage method [58] and testing temperature [59], as 
well as donor age [57] and activity level [60, 61] were also found to be significant factors 
affecting structural properties. 
2.1.2.2 Mechanical Properties of Ligament Substance 
The mechanical properties of a ligament can also be obtained from the same uniaxial tensile test.  
A stress-strain relationship is obtained by normalizing the tensile load by the cross-sectional area 
(i.e. stress) and by normalizing the change in elongation in a defined region of the ligament 
substance by the initial length (i.e. strain).  The parameters that describe the mechanical 
properties of the specimen include the tensile strength, ultimate strain, tangent modulus, and 
strain energy density of the ligament substance can be determined (Figure 3).  Tensile strength is 
the maximal stress and the corresponding strain is the ultimate strain.  The tangent modulus is 
the slope of the linear region of the stress-stain curve and the strain energy density is the area 
underneath the stress-strain curve.  These parameters describe the specimen independent of its 
size and geometry. 
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Figure 3: A typical stress-strain curve from uniaxial tensile testing representing the mechanical 
properties of a ligament[56] 
 
An accurate measurement of the cross sectional area is required for stress calculations.  
To reduce errors associated with oversimplification of the complex shape and distortion of the 
specimen shape via contact measurement methods (i.e. calipers), noncontact methods have been 
used [62-65]. In our research center, the laser reflectance system has been adopted as a method to 
measure both the cross-sectional area and the shape of soft tissues [66].  The second obstacle to 
overcome when determining the mechanical properties of a ligament is accurate measurements 
of tissue strain during experimental protocols.  The use of the clamp-to-clamp distance to 
determine the initial length of the specimen for calculations of stretch or strain can lead to errors 
in strain measurement because the clamp imposes an artificial boundary condition on the tissue 
as well as local damage [67].  To avoid these errors, optical techniques utilizing markers and 
video tracking have been developed [58, 68-72].  The change from the gauge length to its current 
position can be output in terms of percent strain and used in calculating the mechanical 
properties [58, 71, 73-76].   
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2.1.3  Role of Ligament in Joint Function 
It is important to understand the role of ligaments in the context of the joint function as a whole 
along with the aforementioned tensile properties. Joint motion is governed by the direction and 
magnitude of externally applied loads, ligament forces, contact between joint surfaces, and 
muscle activity.  For the knee, motions include a combination of translations: proximal-distal, 
medial-lateral, and anterior-posterior, and rotations: internal-external, flexion-extension and 
varus-valgus.  These translations and rotations describe motion in 6 degrees of freedom (DOF).   
In order to assess joint stability and ligament function, methods for measuring knee 
kinematics as well as the in-situ forces in the knee ligaments in response to external loading 
conditions have been developed.  Due to the difficulty of achieving 6 DOF knee motion 
experimentally, early experiments on ligament function were performed on material testing 
machines limited to a single degree of freedom [77, 78].  An external load would be applied to a 
cadaveric knee and the resulting translation would be measured.  Then, in-situ forces in the 
ligament, such as the ACL, would be measured by repeating the motion after transection of the 
ligament and calculating its in-situ forces using the principle of superposition.  However, by 
constraining DOF, results from these experiments could not reflect the true function of the 
ligament.  Gradually, systems with more DOF were developed [79, 80], prior to the introduction 
of noncontact 6 DOF systems. 
Linkage systems were the first type of system to permit 6 DOF of knee motion to 
measure forces in ligaments indirectly [81].  By fixing the knee flexion angle, the remaining 5 
DOF tibia-femoral motion of a knee and the in-situ forces in ligaments were determined through 
sequential cutting [82]. However, a serious limitation of all linkage systems was that they could 
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not repeat the starting position or the multiple DOF path of motion once the ligament was 
transected.  
A robotic/universal force-moment sensor (UFS) testing system was developed to study 
knee kinematics as well as directly measure the in-situ forces in the knee ligaments in response 
to external loading conditions (Figure 4) [83].  The limitations associated with linkage systems 
were eliminated with the development this testing system that can be operated in force, position, 
or hybrid control.  For example, the starting position and path of motion could be repeated 
throughout the experiment and the in-situ forces in the ligament could be determined in response 
to externally applied loads using the principle of superposition.  The robotic/UFS testing system 
is also advantageous because it provides all of its data for a single specimen, thus eliminating 
interspecimen variation and allowing the greater statistical power by enabling the use of repeated 
measures analysis of variance (ANOVA).  This powerful system has now been adopted by 
laboratories worldwide, which have generated an abundance of new knowledge about knee 
ligaments and joint function. As it pertains to the ACL, it has been particularly important for 
determining the function of the ACL and other knee ligaments including joint kinematics [84], 
in-situ forces [85], the effect of knee motion and external loading on the length of the ACL [81], 
the effect of joint constraints on the in-situ load distribution in the ACL [86], and the 
interdependence of the medial meniscus and ACL [87, 88]. 
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Figure 4: A schematic illustrating a knee joint being tested on the robotic/universal force-moment sensor 
(UFS) testing system at preselected angles of knee flexion, providing 5-degree of freedom joint motion (AP – 
anterior-posterior, PD – proximal-distal, ML – medial-lateral, VV – varus-valgus, IE – internal-external, FE 
– flexion-extension) [89] 
   
2.2 LIGAMENT INJURIES AND CLINICAL MANAGEMENT 
Orthopaedic soft tissue injuries are common with an estimated 800,000 surgeries performed each 
year [90].  More specifically, the ACL is the most often injured knee ligament with well over 
200,000 injuries in the United States with associated costs exceeding $2 billion [3, 4].  There are 
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several treatment options for ACL injuries including conservative (nonsurgical) treatment and 
surgical repair and reconstruction.   
2.2.1 ACL Anatomy and Physiology 
The ACL is a major stabilizer of the knee, aiding in the control of the 6 DOF of knee motion 
(Figure 5) [77].  The primary function of the ACL is to restrain anterior translation of the tibia 
with respect to the femur with secondary roles in internal-external and varus-valgus rotations [2, 
85, 91-95].  It  is located  in the center of the tibiofemoral joint where it crosses from its femoral 
attachment on the medial surface of the lateral condyle to its tibial attachment on the tibial 
plateau in front of and lateral to the anterior tibial spine [96, 97].  The ACL consists of two 
bundles, the anteromedial (AM) and posterolateral (PL) bundles.  The AM bundle is tighter in 
flexion and the PL bundle is tighter in extension [82, 94, 95].  This double bundle structure 
allows the ACL to function throughout all angles of flexion.  While the ACL is located 
intraraticularly, it remains extra-synovial throughout its course [97, 98].  The synovium is a thin 
connective tissue that lines the ACL and protects it from the synovial fluid.  The synovium 
encompasses a network of nerve and blood vessels that are the primary source of nutrition for the 
ACL [98-104].   
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Figure 5: Anterior view of the flexed knee, showing the bones and major stabilizing ligaments 
2.2.2 Incidences and Consequences of ACL Injuries 
The ACL is the most frequently injured ligament in the knee [3, 4, 105-107].  ACL injuries 
commonly occur during sports and work related activities as a result of contact or noncontact 
mechanisms [3, 4, 107].  Contact injuries result from direct impact from an object or individual 
such as a football tackle while noncontact injuries involves sudden deceleration, an abrupt 
change in direction, or jump landing [3, 4, 107].   A midsubstance tear of the ACL has limited 
potential to heal on its own and can lead to chronic knee instability and long term complications 
such as meniscal injuries, failure of secondary stabilizers, and the early onset of osteoarthrosis 
[5, 87, 108-111].   
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2.2.3 Clinical Management of ACL Injuries 
The primary goals of clinical treatment of an ACL injury are to eliminate pain and restore 
ligament function and knee stability.  Also, treatments should manage short term symptoms such 
as pain as well as delay the onset of osteoarthritis.  Conservative treatments and surgery are 
among the treatment options.   
2.2.3.1 Conservative Treatment 
About one-third of ACL injuries are managed with conservative (nonsurgical) treatments.  These 
treatments includes bracing and rehabilitation protocols that aim to regain joint mobility and 
improve neuromuscular function to obtain compensatory functional stability [6, 7].  More 
specifically, they aim to strengthen the hamstrings and quadriceps muscles and restore balance 
and knee range of motion [112].   
 The use of conservative treatment following ACL injury has been debated.  Some have 
reported that the modification of physical activity and rehabilitation restore neuromuscular 
function led to good long term knee function [113, 114], while others have found less favorable 
results.  Anterior and rotatory instability have been reported in a large number of patients, as well 
as subsequent injury to other structures in the knee [12, 115, 116].  Additionally, many 
conservatively treated patients will eventually seek surgical treatment to manage complications.  
Thus, due to the long term consequences and risks associated with ACL deficiency, as well as 
the higher activity levels of younger patients, those who may be satisfactorily treated with non-
surgical intervention include but are not limited to those who are willing to avoid high risk 
activities and those who are more than 40 years of age [5]. 
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2.2.3.2 Surgical Repair 
Due to poor results following conservative treatment, clinicians have investigated surgical 
treatment options for ACL injuries.  In the 1960s, surgical techniques were developed to repair 
an injured ACL by reapproximating the torn ends using sutures [15, 117-119].  However, due to 
the ACL’s limited innate healing capacity, these studies achieved limited success. Feagin et al. 
conducted a study of West Point cadets who underwent suture repair after ACL injury and by 5 
years post-surgery, the majority of patients experienced poor functional outcomes, including 
reinjury, instability, and impairment of daily activities [9].  Similarly, Sandberg et al. 
demonstrated no difference between suture repair and conservative treatment of the ACL [15], 
while Engebretson at al. showed that replacing the injured ACL with a soft tissue graft (ACL 
reconstruction) provided significantly improved functional outcomes [120].  As a result, there 
began a shift in surgical treatment to ACL reconstruction, which was able to immediately restore 
strength and stability to the joint. 
2.2.3.3 ACL Reconstruction 
ACLR has become the gold standard of treatment for ACL injuries for its ability to restore knee 
stability.  Also, many patients hope to prevent the early development of osteoarthritis that is 
inevitable with an ACL deficient joint. 
 ACLR is an arthroscopic procedure where the damaged ACL is removed and replaced 
with a soft tissue autograft or allograft.  The replacement graft is often securely fixed into 
femoral and tibial bone tunnels using interference screws.  The bone-patellar tendon-bone 
(BPTB) graft had been used widely because of its high strength [121].  Also, it has bone blocks 
on both ends that could facilitate initial fixation in the bone tunnels and good osteointegration.  
Follow-up studies have shown good short and mid-term outcomes after ACLR with a BPTB 
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graft [122-124].  However, post-operative complications, such as patellar tendon ruptures, 
arthrofibrosis, loss of quadriceps function, anterior knee pain, and extension deficits were 
reported [125, 126].  More recently, the hamstring tendon (semitendinosus and gracilis) [127-
129] and quadriceps tendon [84, 130-133] grafts have increased in popularity because of the ease 
of graft harvesting and smaller incision as well as reduced postoperative issues such as donor site 
morbidity and knee extensions deficits.  
Regardless of graft choice, there is a prevalence of osteoarthritis after ACLR [109, 134-
136].  The long term degenerative effects on ACL reconstruction are likely caused by the 
inability of the ACL replacement graft to replicate the biomechanical function of the native 
ACL.  It is not possible to replicate the complex anatomy and function of the native ACL with a 
soft tissue graft.  Additionally, the strength of the grafts do not match the stiffness of the ACL 
[57, 121].  These reasons along with inherent healing challenges lead to altered knee kinematics 
resulting in degenerative effects including degeneration of the articular cartilage. 
2.2.3.4 Rationale for Alternative Treatments 
ACLR has been the most widely chosen treatment option for ACL injuries.  Clinicians and 
researchers have sought to improve surgical reconstruction techniques including the graft 
options, fixation strategies, surgical techniques, healing enhancements, and so on.  While ACLR 
can restore joint stability in the short-term, there is a prevalence of osteoarthritis and other 
complications in the long-term.  Recently, it has become obvious that more treatment options are 
needed, especially when a number of new biological interventions have become feasible. 
 An advantageous alternative treatment is to heal or regenerate the native ACL as opposed 
to replacing it.  This approach to treating ACL injuries would have many advantages over 
ACLR, including preservation of its complex anatomy, insertion sites, proprioceptive nerve 
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fibers, and biomechanical properties.  Patients could also avoid the problems associated with 
donor site morbidity seen with ACLR because healing the ACL would eliminate the need for 
graft harvesting and large bone tunnels in the femur and tibia.  Furthermore, by preserving the 
ACL’s structure and biomechanical function, healing the ACL could delay the development of 
osteoarthritis.  Thus, we continue to research and develop an innovative approach involving 
tissue engineering strategies to heal ACL injuries.  
2.2.4 Ligament Healing 
Ligaments have been shown to exhibit varying and unique healing responses following injury.  
For example, the ACL and posterior cruciate ligament (PCL) have a low healing capacity while 
the medical collateral ligament (MCL) has a good healing response, even without surgical 
treatment [137-140].  There are many factors that influence the healing response such as 
mechanical forces, vascularity and nutrition, location in the body (intra-articular versus extra-
articular), and cellularity modulation of the healing process.  Thus, it is helpful to understand the 
healing process of ligaments that exhibit a better natural healing response in order to understand 
how to heal the ACL.   
2.2.4.1 Phases of Ligament Healing 
The events of healing of ligaments can be roughly divided into four overlapping phases: 
hemorrhage, inflammation, repair (proliferation), and remodeling.  Minutes after the ligament 
injury, blood collects and forms a platelet-rich fibrin clot at the injury site and the hemorrhagic 
and inflammatory phases occur over several days.  In the hemorrhage phase, a cascade of cellular 
events occurs that include release of cytokines within the clot followed by the appearance of 
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polymonomuclear leukocytes and lymphocytes.  These cells respond to autocrine and paracrine 
signals to expand the inflammatory response and recruit other types of cells to the wound [141]. 
The reparative phase follows over the next couple of weeks to months.  During this 
phase, fibroblasts recruited to the injury site start forming healing tissue.  Growth factors, 
including transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF) 
isoforms, are involved in modulating the healing [142].  Meanwhile, increased 
neovascularization brings in circulating cells and nutrients to further enhance the healing 
process.  The blood clot quickly turns into newly formed healing tissue that is composed of an 
aggregation of cells surrounded by a matrix.  But, its histomorphological appearance and 
biochemical composition is different from that of an uninjured ligament.  Notably, there is a 
homogenous distribution of smaller diameter collagen fibrils which is in stark contrast to the 
bimodal distribution of the normal ligament [33, 143, 144].  Biochemically, it contains elevated 
amount of proteoglycans, a higher ratio of type V to type I collagen, and a decrease in the 
number of mature collagen cross links. 
Then the remodeling phase follows for months to years after the injury. In this phase, 
cellularity and levels of collagen type III are decreased while the matrix is realigned in response 
to loading applied to the tissues.  On the other hand, the diameter of collagen fibrils remains 
small while the level of collagen type V remains elevated for years after injury [143-147].  
Interestingly, the type V collagen has been shown to play a central role in the regulation of the 
lateral aggregation of smaller collagen fibrils.  Thus, an elevated type V collagen could be 
associated with the inferior mechanical properties of healing tissue [148, 149]. 
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2.2.4.2 MCL Healing 
The healing process of the MCL follows this general healing pathway as described above.  Thus, 
it serves as a good model for the study of histological, biochemical, and biomechanical changes 
with time.  It has been shown that the process of MCL healing is greatly impacted by treatment 
[150-154].  Laboratory and clinical studies have shown controlled mobilization is superior to 
immobilization [153, 155, 156]. As a result, nonoperative repairs have a better outcome to 
surgical repairs.  In our research center, a severe “mop-end” injury model of the rabbit MCL that 
tears its midsubstance while simultaneously damaging its insertion sites has been developed and 
used to compare nonoperative treatment without mobilization to surgical repair with a brief 
period of mobilization [156].  After 12 weeks of healing, there were no significant differences in 
varus-valgus knee rotation, in-situ force of the MCL, or tensile properties between repaired and 
non-repaired MCL [156].  Based on these studies, clinical management (i.e. bracing) with early 
controlled range of motion exercises as soon as pain subsides is suggested [157, 158]. 
 While the MCL heals with non-operative treatment and the stiffness of the healing femur-
MCL-tibia complex (FMTC) begins to approach normal levels, the CSA of the healed tissue 
continues to increase with time, measuring as much two and a half times its normal size by 52 
weeks after injury [155]. Meanwhile, the mechanical properties of the healing MCL remain 
consistently low when compared to those for the normal ligament and do not improve with time.  
In other words, the healing process involves making a larger quantity of lesser quality 
ligamentous tissue.  Moreover, studies also show that the rate of healing of the ligament is 
asynchronous with the insertion sites because of its anatomical and morphological complexity. 
 There is also evidence that activity level could influence the rate of healing [159]. A goat 
model was used because it has more robust activity as well as larger size than the rabbit.  With 
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this model, the stiffness and ultimate load of the healing goat FMTC are closer to control values 
at earlier time periods than those from the rabbit model. 
2.2.5 Challenges for ACL Healing 
Unlike the MCL, an extra-articular ligament, the ACL does not undergo the normal phases of 
healing after injury.  It has been observed that the remnants of ACL degenerates rapidly after 
injury [160, 161].  There are several biological and mechanical factors that influence this process 
[162-166].  First, numerous studies have reported the lower intrinsic healing capacity of the ACL 
compared the MCL [167-169], and reduced cellular proliferation [170], ECM production [170], 
gene expression [171, 172], migration [173], and less vascularity [22, 101] have all been 
identified as contributing factors.  Additionally, the synovium surrounding the ACL contains 
vasculature and nerves.  When the synovium is disrupted, it takes 3-6 weeks to regenerate 
following ACL injury [100, 164, 174].  Without the synovium, the synovial fluid can enter the 
injury site and prevent hematoma formation, and limit the initial step of ligament healing.  
Further, it has been shown that the two ends of a ruptured ACL retract and form a large gap 
between them; thus, making it more difficult to restore continuous tissue [164].  The gap 
between the torn ends is further exaggerated by the lack of mechanical stabilization following 
injury and causes altered loading and kinematics. 
 These multiple factors explain why ACL healing is challenging.  Thus, creating an 
appropriate environment in which the ACL could heal is essential as well as addressing the 
biological and mechanical factors that affect the healing response.  Therefore, this dissertation 
research aims to address some of these healing complexities to achieve ACL healing. 
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2.2.6 New Approaches to ACL Healing 
Just as the challenges to ACL healing have been due to biological and mechanical factors, 
strategies for healing the ACL have been developed similarly.  With the advances in tissue 
engineering and regeneration, many biological approaches to ACL healing have been developed 
resulting in new tissue formation to a varying degree.  In general, the ACL healing rate is slow 
and the lack of loading to the healing ACL has deleterious effects on its attachments to bone.  
Thus, mechanical augmentation that could maintain joint stability while simultaneously loading 
the healing ACL has been used in combination with biological augmentation to incite more 
robust tissue healing.   
2.2.6.1 Biological Augmentation 
Steadman and coworkers developed a microfracture technique that involves making 
multiple holes in the subchondral bone at its femoral attachment to encourage release of marrow 
elements to form hematoma and provide an enriched environment for ACL healing [175].  They 
have used this approach to successfully treat active patients over 40 years of age [175].  With 
clinical evidence for the potential of ACL healing other biological strategies have been employed 
for “hard to heal” soft tissues including hyaluronic acid, growth factors, mesenchymal stem cells, 
platelet-rich plasma (PRP), and ECM bioscaffolds for partial ACL defects as well as full ACL 
transection [16, 17, 19, 163, 166, 176].  These studies have shown that biological augmentation 
could increase vascularity, more tissue formation and improved biomechanical properties of the 
healing ACL.  Clinically, patients with partial ACL tears with suture repair and bone marrow 
plasma were able to return to sports 4-5 months and experienced good healing up to 2 years 
based on MRI scans [177].  
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In addition to early work on biological augmentation to heal partial ACL injuries, Murray 
et al. have used collagen-platelet-rich plasma (C-PRP) as a bioscaffold for healing a fully 
transected and sutured porcine ACL [178].  At 4 weeks, the linear stiffness under uniaxial 
tension, the load at yield and at failure were more than 2 times that of the suture repaired control 
group [178].  These improvements persisted up to 3 months post-operatively with a 320% 
increase in linear stiffness and a 76% greater yield load than suture repair alone [18].      
The potential advantages of using porcine small intestinal submucosa (SIS) ECM to heal 
the transected ACL were examined [19, 179, 180].  The ACL was first surgically transected and 
then underwent suture repair.  Then, and ECM-SIS sheet was used to wrap around the injury site 
before injecting ECM hydrogel into the transected site (Figure 6).  Suture repair alone served as 
the control group.  After 12 weeks, the CSA of the ACL following ECM-SIS treatment was 4.5 
times over that of the suture repair group (127 ± 90% vs. 34 ± 25%, respectively).  The function 
of each stifle joint was assessed using the robotic/UFS testing system.  The anterior-posterior 
tibial translation for the ECM-treated group, in response to a 67-N anterior-posterior tibial load, 
had statistically significant improvement as compared to those for the suture repair control.  At 
30° of joint flexion, the anterior-posterior tibial translation was 8.6 ± 2.0 mm which was less 
than that of the control group.  The in-situ force in the healing ACL was found to be nearly 2 
times higher than that of the control group. Similar results were found at 60° and 90° of joint 
flexion. 
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Figure 6: Illustrations of the ECM-SIS treatment for a transected ACL in a goat model [19]  
 
Afterward, the healing ACL was exposed and an abundance of continuous neo-tissue 
formation could be seen, but there was hypertrophy.  Histologically, the healing ACL had an 
organized collagen matrix with spindle-shaped cells.  Tensile testing of the FATC was done and 
the stiffness for the treated group was 2.4 times that of the suture repair control group.  These 
results suggest biological augmentation could indeed enhance ACL healing [19]. 
A preliminary experiment involving a longer time point (26 weeks) was also conducted. 
In this case, the healing of the ACL continued as its collagen fibers had become completely 
aligned and packed.  During tensile testing, the mode of failure was at the femoral insertion site 
rather than the original transection site.  While the healed ACL had become stronger, the 
insertion sites became weakened due to the lack of adequate loading of the entire FATC during 
the slow healing process.  These results also suggested that some form of mechanical loading of 
the ACL during its healing would be needed to limit the deleterious effects of disuse atrophy of 
its femoral and/or tibial insertion sites. 
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2.2.6.2 Mechanical Augmentation 
Literature has suggested that mechanical augmentation by means of sutures could help 
stabilize the knee with an injured ACL.  Fleming et al. used suture augmentation, in which 
sutures were passed from bone to bone in a porcine model to reduce anterior joint laxity [181].  
In our research center, we have also used sutures for mechanical augmentation in a series of goat 
experiments.  Our first study was to determine the best location of the tunnels for suture (#2 
Fiberwire sutures) augmentation on stifle joint stability following complete ACL transection 
[182].  We found that placing the sutures from the anterior footprint of the femoral origin to the 
medial aspect of the tibial footprint, the anterior tibial translation as measured by the 
robotic/UFS testing system was restored to within 3 mm of the intact joint following suture 
augmentation and the in-situ force was similar to that of the intact ACL (Figure 7).  Furthermore, 
these data represented 54-76% improvement over suture repair.  It was concluded that suture 
augmentation, when placed close to the ACL insertion, could provide good initial joint stability 
which could aid ACL healing.  Another study also showed the relative contribution of the soft 
tissues in resisting the anterior tibial load [183].  Under 67-N anterior tibial load, the ACL 
provided the dominant support in the intact joint.  In the case of ACL-deficiency, the MCL and 
medial meniscus carried significant loads. At 30° of joint flexion, these loads reached up to 36% 
and 53% of the intact ACL, respectively.  Following suture repair of the ACL, the in-situ force 
was 81% of the intact ACL while that for the augmentation sutures was 103%.  Similar results 
were seen for 60° and 90° of joint flexion[183].  It could be concluded that suture augmentation 
had provided sufficient initial joints stability and concomitantly lowered the loads on the MCL as 
well as the medial meniscus and potentially, reduced their chance of injury from overloading. 
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Figure 7: Diagram of tunnel locations for augmentation sutures. A) FA is located anterior to the ACL 
footprint at the femoral origin and B) TM is located medial to the footprint at the tibial insertion [182]  
 
Finally, an in-vivo study was done to see whether suture augmentation could actually 
heal a surgically transected ACL [184].  After 12 weeks, the anterior-posterior tibial translation 
for the suture augmentation group was about 20% lower than that of the suture repair group 
while the in-situ force in the healing ACL was more than 50% higher that the suture repaired 
ACL.  Upon dissection, the ACL was found to heal with significant neo-tissue formation.  In 
terms of the structural properties of the FATC, the linear stiffness was 75% greater than that of 
the suture repair group.  It was concluded that suture augmentation could provide the needed 
stability to the stifle joint for the intrinsic healing of the ACL to take place.  In addition, such 
augmentation would reduce the forces carried by secondary structures in an ACL deficient stifle 
joint in order to help avoid injury to the MCL and medial meniscus.  
2.2.6.3 Combined Biological and Mechanical Augmentation 
With the knowledge that biological and mechanical augmentation could each individually 
enhance ACL healing, we then asked the research question whether their combination may work 
synergistically to further accelerate the healing process.  It was hypothesized that since the 
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mechanical augmentation would stabilize the knee immediately after surgery, it could help the 
biological augmentation to stimulate and accelerate the ACL healing. 
For this purpose, we designed a novel Mg-based ring to bridge the gap between the two 
torn ends of the ACL (Figure 8).  It serves as an internal splint for mechanical augmentation 
while simultaneously load the healing ACL as well as its insertion sites to prevent disuse 
atrophy.  The function of the Mg ring repaired ACL was first evaluated in an in vitro study using 
a goat model.  Following the application of a Mg ring, the anterior tibial translation of the 
repaired ACL was reduced by 60-70% from the ACL deficient state as measured by the 
robotic/UFS testing system.  This was within approximately 3 mm of that of the intact joint 
[185].  Mg ring repair could also restore the in-situ forces of the repaired ACL to within ± 5 N of 
the levels of the intact ACL [185].  These data suggest that the Mg ring is indeed a suitable 
device for mechanical augmentation. 
 
 
Figure 8: Mg ring repair of the ACL including bone tunnels and placement of repair and fixation sutures (A) 
and fixation of the ring using commercially available orthopaedic devices (B) [20]  
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With the promising in vitro results, the Mg ring was used in combination with ECM 
bioscaffolds in an in vivo animal study [186].  Since Mg is a biodegradable and bioresorbable 
material, it is hypothesized that the Mg ring would degrade as the ACL healing progresses and 
its mechanical function could be replaced by the healing ACL (Figure 9) [20].  After surgical 
transection, the Mg ring was sutured to connect the stumps of the ACL followed by wrapping the 
transection site with an ECM sheet and injection with ECM hydrogel [186].  After 6 weeks of 
healing, the device had degraded about 40% and translucent healing tissue was seen [186].  By 
12 weeks, the function of the stifle joint as determined by the robotic/UFS testing system in 
response to a 67 N anterior-posterior tibial load, the anterior-posterior tibial translation of the Mg 
ring repaired group were 9.8 ± 1.5, 4.0 ± 1.5, and 3.4 ± 1.3 mm at 30°, 60°, and 90° of joint 
flexion, respectively and these values were lower than that of the suture repair group (11.8 ± 3.4, 
14.4 ± 4.2, 10.8 mm, respectively p< 0.05).  The in-situ forces carried by the ECM + Mg ring 
repair group were approximately twice that of the suture repair group.  Similarly, the structural 
properties of the FATC for ECM + Mg ring repair group showed that stiffness and ultimate load 
reached 77 ± 33 N/mm and 371 ± 240 N, respectively.  These values were 3 times greater than 
the suture repair group [186].  These results also compared favorably to those following ACL 
reconstruction in the same animal model.  The stiffness and ultimate load values were 1.5 to 1.8 
times higher than those following ACL reconstruction (37.2 ± 22 N/mm and 268.8 ± 175.8 N, 
respectively) in a goat model at 12 weeks [186, 187].  These results are exciting as the combined 
biological and mechanical augmentation therapy has worked in synergy to accelerate ACL 
healing.  This dissertation includes the study of ECM + Mg ring repair after 26 weeks of healing 
to determine if these benefits will persist. 
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Figure 9: The Mg-based ring was hypothesized to degrade with time while the healing ACL would 
gradually bear the loading 
2.3 MAGNESIUM AS A BIOMATERIAL FOR ORTHOPAEDIC APPLICATIONS 
2.3.1 Bioresorbable Orthopaedic Biomaterials 
Biomaterials are used in orthopaedic surgery for bone substitutes, fixation and stabilization of 
fractured bones, ligament and tendon reconstruction procedures, total joint arthroplasties, and so 
on.  Historically, non-degradable metals, namely stainless steel and titanium alloys, have been 
used because they possess good mechanical strength, biocompatibility, and corrosion resistance 
[188].  However, because they remain in the body permanently, secondary surgeries are required 
for their removal.  In addition, due to wear processes, they sometimes release toxic metallic 
particles into the body that could lead to a cytotoxic response [125, 189-191]. 
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With the advent of functional tissue engineering, bioresorbable materials have gained 
much attention and their usage has increased, as they could be replaced by the patient’s own 
tissue as well as be used for delivery of bioactive molecules to improve healing of various hard 
and soft tissues.  These biomaterials are chosen based on the needed properties for the desired 
application, including specific mechanical properties, porosity, degradation profiles, 
biocompatibility, and adherence and incorporation into adjacent tissue [192]. 
For the repair or replacement of ligaments and tendons, there are a number of options for 
biomaterials such as fibrous collagen, ECM, silk, and synthetic polymer scaffolds that have been 
explored and used [193, 194].  In addition, hydrogels have become an attractive option to fill 
irregularly-shaped voids and aid in the delivery of cells, growth factors, and other bioactive 
molecules [195].  For regeneration of the soft tissue-to-bone interface (e.g. ACL insertion to 
femur), polymers have become a popular choice as they can be engineered to possess multi-
phasic properties [196]. 
However, polymer materials may not be an ideal choice for some orthopaedic 
applications.  When poly-L-lactic acid (PLLA) interference screws were used for graft fixation 
during ACLR, the devices often fractured during implantation due to their brittleness [197].  
Furthermore, their rate of degradation varied greatly between patients and in most cases was very 
slow, with the screw remaining mostly intact even after 2 years [198].  Also, after degradation, 
the void left was not filled with regenerating bone.  A 10 year follow-up study showed that an 
osseous cyst had formed after complete degradation of an interference screw [199].  Recently 
developed composite materials such as PLLA with tri-calcium phosphate (TCP) particles are 
designed to address the inadequate osteointegration, but results have been mixed as some studies 
reported improved results [198] while other reported poor integration [200].  
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2.3.2 Historical Use of Mg for Orthopaedic Implants 
The history of biodegradable Mg implants started shortly after the discovery of elemental Mg by 
Sir Humphrey Davy in 1808 [201].  The most influential pioneer was the physician Erwin Payr 
from Austria whose versatile clinical applications and reports inspired the advancement of the 
field of biodegradable Mg implants to various surgical areas.  In 1900, Payr introduced the idea 
of using Mg plates and sheets in joint arthroplasties to regain or preserve joint motion.  Inspired 
by Payr, Chlumsky used Mg to regain motion in stiff joints (e.g. knee ankylosis) [201]. More 
specifically, he interposed 0.1-0.8 mm thick Mg sheets between freshly separated bone surfaces 
in the knee joints of dogs and rabbits [201].  The Mg sheets were completely corroded after 18 
days and the joint motion was restored after bony separation of ankylotic joints in animals and 
humans [201]. 
Payr also proposed possible Mg implants in orthopaedic applications including fixator 
pins, nails, wires, pegs, cramps, sheets and plates.  Following suit, Lambotte investigated the use 
of a Mg nails as well as a Mg plate and screw fixation for treatment of bone fractures of children 
resulting in good to total restoration of the joint function with no pain in the operated area [201].  
It was also noted that Mg seemed to be a promoter of bone formation and healing [201].  
Similarly, Maier investigated pins made of spindle-shaped Mg sheets in two humerus fractures in 
humans and Troitskii and Tsitrin reported the successful treatments of 34 cases of pseudoarthritis 
with a plate and screw combination made of a Mg-Cd alloy [201]. 
Nearly all patients benefited from the treatment with Mg implants.  While most patients 
had no pain and almost no infections were observed during post-operative follow-up, they 
experienced subcutaneous gas cavities caused by rapid implant corrosion [201].  Since the 
problem of controlling the corrosion of Mg in vivo had not been sufficiently addressed, many 
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surgeons had turned to use the more corrosion-resistant materials, such as stainless steel [201].  
Thus, Mg was no longer seriously considered as a biomaterial. 
2.3.3 Recent Advances in Mg-Based Materials 
In recent years, there has been a renewed interest in the use Mg and its alloys for orthopaedic 
applications because of advances in alloying, processing, and coating to engineer desirable 
mechanical properties, corrosion rates, and biocompatibility. As a lightweight metal with 
mechanical properties similar to natural bone, a natural ionic presence with significant functional 
roles in biological systems, and in vivo degradation via corrosion in the electrolytic environment 
of the body, Mg-based implants have the potential to serve as biocompatible, osteoconductive, 
degradable implants for load-bearing applications.  A search of Web of Science using 
“magnesium” and “stainless steel” as search queries under the category “biomaterials” revealed 
that the number of publications on Mg has exponentially increased in the past ten years, 
compared to those on stainless steel (Figure 10).  
34 
 
Figure 10: Histogram showing the number of publications each year on research on Mg and its alloys 
and stainless steel as biomaterials  [20] 
2.3.3.1 Mechanical Properties 
Mg-based materials have significantly lower moduli than titanium-based materials (41-45 GPa 
vs. 110-117 GPa) [202].  As a result, their mechanical properties are closer to those of cortical 
bone and could reduce the level of stress shielding.  In terms of tensile strength, Mg-based 
materials are 3-16 times stronger than polymers (160-250 MPa vs 16-69 MPa).  They are also 
more ductile and have higher ultimate strain that reaches up to 16% which could reduce the risk 
of device fracture during implantation.  
However, pure Mg may not possesses mechanical properties strong enough for load-
bearing applications [203].  Alloying of Mg with various elements has led to the development of 
many materials with greatly enhanced mechanical properties.  With enhanced mechanical 
properties, Mg alloys are better suited for orthopaedic applications. The most common Mg alloys 
are those including aluminum (Al), which increases the corrosion resistance by forming an 
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insoluble layer of Al2O3 on its surface when exposed to simulated body fluid (SBF) [204].  Al 
has commonly been alloyed with zinc (Zn) to produce popular alloys AZ31 (3% Al, 1% Zn), 
AZ61 (6% Al, 1% Zn), and AZ91 (9% Al, 1% Zn) [204-206].  Calcium (Ca) has also commonly 
been used as an alloying element in Mg alloys particularly attractive for bone healing 
applications [207, 208].  Additionally, rare earth metals such as yttrium (Y), zirconium (Zr), and 
neodymium (Nd) have been used in Mg alloys due to their improvements on the mechanical 
properties, creep resistance, and corrosion rate of Mg [64, 209-211]. 
 Other strategies have been employed to modify the microstructure of the Mg material to 
change its properties in addition to alloying.  For example, a Mg calcium phosphate scaffold was 
designed to be porous in order to have its mechanical properties similar to those of cancellous 
bone, thus making it ideal to be used as a bone substitute [212].  Others have investigated the 
growth of monocrystalline forms of Mg (single crystal Mg), which has improved ductility and 
exhibits superplastic behavior [213-217]. 
2.3.3.2 Controlled Degradation 
The corrosion mechanism of Mg is very complex.  When subject to aqueous environments, Mg 
and its alloys are known to degrade via an electrochemical reaction producing magnesium 
hydroxide and hydrogen gas (Figure 11).  The overall corrosion reaction of Mg in aqueous 
environments is below: 
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The production of OH- causes a pH increase which favors the formation of Mg hydroxide layer 
by the precipitation reaction. 
 
 
Figure 11: Schematic of reactions between Mg in an aqueous environment [218]  
  
In addition to the challenges in understanding the corrosion mechanisms of Mg alloys in 
biological environments, there is the issue of controlling the corrosion rate and mode.  The initial 
corrosion rate of Mg alloys is often too fast, and a highly reactive Mg alloy surface can be 
harmful for the biological environment.  Strong hydrogen bubbling takes place when a bare Mg 
alloy sample is introduced to any type of simulated body fluid.  Combined with this, local 
alkalization in the vicinity of the surface can be observed.  So while the general corrosion rate 
needs to be tailored to match the desired lifetime of the device, it is even more desirable to have 
a controlled time-dependence of the corrosion rate.  For instance, initial slow corrosion would 
allow development of a stable bio-interface and would enable the mechanical integrity of the 
device to be maintained for the required period.  This should be followed by faster dissolution 
and finally by a complete removal of the implant by soluble corrosion products.  Exploration of 
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novel alloys as well as surface modification approaches have been developed for the control of 
biodegradation of Mg alloys.  The challenge in both strategies is to combine optimization of the 
corrosion behavior with the tailored and desired performance for the specific targeted application 
[219]. 
 Alloy development for biodegradable implants requires consideration of tailored 
corrosion behavior, suitable mechanical properties, excellent biocompatibility, and if possible 
even desired bioactivity [219].  By meticulous control of alloy chemistry (alloying elements and 
impurities), processing, heat treatments and resulting microstructures, significant progress has 
been made in the development of novel alloys with promising in vitro and in vivo properties 
[220].  One alloy system of interest for biodegradable implants is Mg alloyed with Y, Zr, and 
rare earth elements, but Mg-Ca and Mg-Ca-Zn alloys have also been investigated.  Other 
alloying elements explored are Ca, Mn, Zn, and Sr, which are expected to lead to additional 
beneficial biological effects [221].  For biodegradable Mg alloys, degradation rates of ultra-high 
purity Mg have been shown to be very low both in vitro and in vivo [222]. 
 The different approaches studied for coatings and surface modification of biodegradable 
Mg alloys include anodization, CaP coatings, biodegradable polymers and so on [219].  A 
suitable coating for degradable Mg based implants should initially offer good protection to 
mitigate the negative effects related to fast burst of dissolution of a freshly implanted device, 
then degrade in a controllable manner, and finally enable complete dissolution of the coating and 
the underlying substrate.  The required time-profile of degradation of course depends on the 
targeted application.  One drawback in the design of coatings for tailored degradation is the 
unknowns between a test of degradation rate in the laboratory and true performance of the 
coating in vivo [219]. 
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2.3.3.3 Biocompatibility 
Mg is essential to human metabolism and is naturally found in bone tissue [223-228].  It is the 
fourth most abundant cation in the human body, with an estimated 1 mol of Mg stored in the 
body of an adult, with approximately half of the total physiological Mg stored in bone tissue 
[224].  Mg is a co-factor for many enzymes, and stabilizes the structures of DNA and RNA 
[223].  The level of Mg in the extracellular fluid ranges between 0.7 and 1.05 mmol/L, where 
homeostasis is maintained by the kidneys and intestines [224].  While serum Mg levels 
exceeding 1.05 mmol/L can lead to muscular paralysis, hypotension and respiratory distress 
[226], and cardiac arrest occurs for severely high serum levels of 6-7 mmol/L, the incidence of 
hyper-Mg is rare due to the efficient excretion of the element in the urine [224, 226, 227]. 
 Witte et al. explored the in vivo degradation of Mg-based alloys, comparing two alloys 
containing only Al and Zn, and two alloys with rare earth element combinations [211, 229].  The 
Al-Zn alloys contained 3 wt% Al and 1 wt% Zn (AZ31), and 9 wt% aluminum and 1 wt% Zn 
(AZ91).  The first rare-earth alloy was composed of 4 wt% Y and 3 wt% of a rare earth metal 
mixture consisting of Nd, Ce, and Dy (WE43).  The final rare-earth alloy consisted of 4 wt% Li, 
4 wt% Al and 2 wt% of a rare earth element mixture of Ce, La, Nd, and Pr (LAE442).  The 
implants consisted of rods 1.5 mm in diameter and 20 mm in length, inserted into the femur of 
guinea pigs.  The implants were harvested at 6 and 18 weeks.  Complete degradation was 
observed in 18 weeks [229].  Significantly increased bone area was observed in all groups at 
week 6 and 19, in comparison to the polymer control [211].  Adverse effects due to the formation 
of subcutaneous gas were not observed. 
 Li et al. conducted a preliminary in vitro assessment of the cytotoxicity of pure and 
surface treated Mg using bone marrow cells of mice [227].  The results show positive cell 
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proliferation and viability after 72 hours of incubation with Mg and no sign of growth inhibition.  
These studies along with numerous others support the viability of Mg-based materials as 
lightweight, degradable, biologically compatible and biologically active (i.e. osteoconductive) 
orthopaedic implants[202]. 
2.3.3.4 Suitability with Imaging Modalities 
Mg alloys do not interfere with magnetic resonance imaging unlike other metallic materials, such 
as titanium or stainless steel alloys.  Ernsterger et al. evaluated artifacts caused by Mg-based 
intervertebral discs and observed minimal interference by Mg-based discs was comparable to 
that of the polymer control [230].  At the same time, Mg-based alloys can be imaged in vivo 
using computed tomography allowing accurate assessment of device degradation and bone 
formation [231]. 
2.3.4 Rationale for Use of Mg for Regeneration of the ACL 
Mg and its alloys possess advantageous properties with excellent potential for mechanical 
augmentation of an injured ACL.  They are lightweight and possess suitable mechanical 
properties such that they could withstand loading in vivo. Additionally, their ductility could 
allow for small deformations to conform to the anatomy of the knee and potentially prevent 
damage to the cartilage, menisci, and other structures.  Also, a Mg alloy and surface coating 
combination could be strategically selected to tailor a corrosion rate desirable for ACL healing 
applications and allow for the gradual transfer of loading from the implant to the healing ACL 
throughout the healing process (3-6 months).  Finally, the known biocompatibility of Mg would 
be attractive for the clinical translation of a Mg implant for ACL healing. 
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3.0  OBJECTIVES 
3.1 BROAD GOALS 
An advantageous alternative treatment option to ACLR is to heal the injured ACL which allows 
for the preservation of the normal ACL anatomy and function and eliminates the need for graft 
harvesting.  In our research center, an innovative approach to healing the ACL was developed 
using an extracellular matrix (ECM) sheet and hydrogel along with a novel metallic implant 
made of magnesium (Mg) and shaped like a cylinder, or a Mg ring designed to bridge the gap 
between the two ends of a torn ACL.  The biological augmentation provided by the ECM 
scaffolds has been shown to incite and accelerate new tissue growth.  The mechanical 
augmentation provided by the Mg ring can restore stability to the knee joint immediately post-
operatively and load the healing ligament throughout the healing process preventing disuse 
atrophy of the insertion sites.  Additionally, the entire ECM + Mg ring repair construct can be 
resorbed by the body as the healing tissue begins to bear load.  Short term preclinical studies in 
the goat model have yielded promising results demonstrating feasibility of ECM + Mg ring 
repair of an injured ACL.  The overall goal of this dissertation is to further develop and evaluate 
ACM + Mg ring repair through the completion of the Specific Aims. 
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3.2 SPECIFIC AIMS AND HYPOTHESES 
Specific Aim 1: To characterize single crystal Mg coated via micro arc oxidation. Previous 
studies of ECM + Mg ring repair in a goat model have shown that an implant made with single 
crystal (SC) Mg coated via micro arc oxidation can be completely resorbed by 12 weeks and 
yield favorable results.  Thus, resorption of the Mg ring implant by 12 weeks in vivo is an 
adequate degradation rate for the application of ACL healing.  This was achieved by matching 
SC Mg coated via micro arc oxidation to the in vitro degradation rate of Mg ring implant used in 
a previous in vivo study in a goat model for 12 weeks of healing.  Additionally, characterization 
of the in vitro corrosion, coating surface and structural properties was conducted.   
 
Specific Aim 2: To evaluate ECM + Mg ring repair after implantation and long-term healing in 
a goat model. ECM + Mg ring repair of surgically transected goat ACL was performed and 
evaluated after 26 weeks of healing.  Cytology and total protein content of synovial fluid were 
used to assess the biocompatibility of the treatment.  Gross morphology and histology were used 
to observe the healing ACL in terms of collagen fiber morphology and cellular response.  Joint 
kinematics and in-situ forces in the healing ACL were measured to quantify the function of the 
ACL.  The structural properties of the healing femur-ACL-tibia complex (FATC) were obtained 
and used to assess tissue quality and failure mode.  Based on the outcomes from earlier work 
using ECM + Mg ting repair, it was hypothesized that the advantages of ECM + Mg ring repair 
would persist to 26 weeks characterized by continuous collagen fibers without atrophy of the 
insertion sites as evident by failure mode. 
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Specific Aim 3: To develop and evaluate the Mg ring implant for use in humans.  In preparation 
for future use in humans, the Mg ring implant was scaled up considering the anatomy of the 
human ACL.  Then, the redesigned implant for use in humans was machined and implanted into 
human cadaver knee specimen to evaluate its ability to restore joint stability and load the ACL 
immediately post-operatively.  Lastly, a finite element model of the implant in the human knee 
was developed for further observation of the von Mises stress values and concentrations within 
the model and evaluation of future deign iterations of the implant.  It was hypothesized that Mg 
ring repair would be able to restore anterior tibial translation of the Mg ring repaired ACL 
within 5 mm of that of the intact joint under externally-applied loads and in-situ force in the 
repaired ACL to levels ± 20 N to that of the intact ACL. 
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4.0  MATERIAL CHARACTERIZATION 
4.1 INTRODUCTION 
The Mg material used for the application of ACL healing was chosen for its clinical relevance 
and previous preclinical use.  Specifically, a monocrystalline or single crystal (SC) Mg substrate 
was found to be most suitable because of its lack of grain boundaries resulting in higher ductility 
that could be advantageous for the Mg ring implant.  Additionally, the purity of single crystal Mg 
without alloying elements as well as minimization of the defect concentration in particular, 
dislocations (edge, screw) and stacking faults is highly relevant clinically to achieve the desired 
mechanical ductility, strength and bio corrosion. 
As ACL healing is relatively slow and takes weeks, a strategy that allows for slow 
corrosion initially and development of a stable bio-interface that would enable the mechanical 
integrity of the implant to be maintained for a required period of 6 to 12 weeks is needed.  
Afterward, a faster dissolution and finally a complete resorption of the implant by soluble 
corrosion products would be desired.  With the selection of SC Mg as the metallic substrate, a 
micro arc oxidation (MAO) coating strategy was selected.  While there are several types of 
surface modification approaches including CaP coatings and biodegradable polymers, MAO 
could provide the aforementioned properties [232]. 
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Micro arc oxidation (also known as anodization and plasma electrolytic oxidation) is an 
electrolytic passivation process that is used to increase the thickness of the natural oxide layer on 
the surface of metals.  A metal is placed in an electrolytic solution and a voltage is applied 
resulting in high temperatures and a sparking phenomenon.  The sparking contributes to the 
porosity that is characteristic of MAO coatings (Figure 12).  There is an outer porous layer and 
an inner barrier layer.  The outer porous layer does not contribute to corrosion protection as the 
pores act as passages for corrosive media.  The inner barrier layer however is often considered to 
have a major influence on the corrosion resistance as this layer is denser and compact with fewer 
pores [232]. 
 
 
Figure 12: Schematic description of coating prepared using MAO process [218]  
 
Specific Aim 1 includes the use of hydrogen evolution measurement to quantify the 
corrosion profile used in a previous in vivo study in a goat model after 12 weeks of healing 
referred to as “healing study” in subsequent sections.  Then, SC coated for various periods of 
time also underwent hydrogen evolution measurement to match the corrosion profile of the Mg 
ring implant used in the “healing study”.  Additionally, this novel material-coating combination 
underwent in vitro immersion testing to determine the corrosion behavior as determined by Mg 
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ion concentration, pH, and change in mass.  The coating and surface properties were also 
characterized. 
 
4.2 METHODS 
4.2.1 Preparation of Metallic Substrates 
The corrosion, coating, and surface properties of MAO coated SC were characterized.  The 
actual Mg ring implants were used for characterization specific to the geometry of the device and 
to determine the in vitro corrosion rate that could be used as a standard for future device 
development. Disks were used for understanding how the properties varied independent of the 
shape such as corrosion rate as a result of coating time or substrate material.   
4.2.1.1 Mg Ring Implants 
SC Mg cylinders were machined into the geometry of the Mg ring implant (Figure 13) at the 
Swanson Center for Product Innovation (SCPI).  To produce the implants, the inner and outer 
diameters were first turned using a lathe.  Then surface holes and other features were added 
using CNC milling with a custom-made mandrill.  These Mg ring implants were used for 
hydrogen evolution measurements and subsequent in vivo studies (Figure 14).   
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Figure 13: Geometry of the Mg ring implant[21]  
 
 
Figure 14: Mg ring implants manufactured with single crystal Mg 
4.2.1.2 Pure Mg Disks 
Commercially available 99.9% Mg (Goodfellow Corporation, Coraopolis, PA) and SC Mg 
obtained from the Institute of Solid State Physics (Beijing, China) were used. Cylindrical 
samples of 10 mm diameter by 1 mm thickness (prior to polishing) with a 1 mm diameter hole 
were machined by the University of Pittsburgh’s Swanson Center for Product Innovation (SCPI). 
The samples were successively polished using 320-grit, 600-grit, and 1200-grit silicon carbide 
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(SiC) abrasive paper. After polishing, the samples were rinsed with ethanol and air dried.  These 
Mg disks were used for in vitro immersion testing. 
4.2.2 Micro Arc Oxidation Coating 
Each of the Mg samples underwent micro arc oxidation coating in a 6 M Na3PO4 + 8 M 
Na2SiO3•5H2O + 4 M KF electrolytic solution prepared using deionized water and continuously 
stirred with a magnetic stirrer.  The coatings were formed in a stainless steel container (1 L of 
solution used) surrounded by an ice bath (Figure 15). The Mg samples were immersed in the 
electrolytic solution using a 0.25 mm titanium wire passed through the 1 mm diameter hole at 
one end and the titanium wire was attached to the pulse source at the other end. Using an 
adjustable DC pulse source, the coatings were obtained under constant applied potential of 300V 
for 2 and 5 minutes with the uncoated samples as the control.  After coating, the samples were 
rinsed with ethanol, air dried, and stored in a desiccator.  
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Figure 15: The setup for MAO coating: 1) Mg sample, 2) electrolytic solution, 3) stainless steel container, 4) 
ice bath, and 5) power source 
4.2.3 Corrosion Characterization 
Techniques used for exploring the corrosion behavior of metallic materials in general, including 
Mg, involve immersing the samples in a corrosive solution [219].  There are numerous methods 
for measuring the corrosion rate of Mg in aqueous solutions, which can be used independently or 
simultaneously.  These include weight loss (mass loss), hydrogen collection, electrochemical and 
non-electrochemical methods as well as chemical analysis of the solution.  Due to the simplicity 
and availability of resources, non-electrochemical methods were used for the characterization of 
the MAO coated SC substrates.  Weight loss measurements are well established and hydrogen 
collection methods can be readily used for monitoring the instantaneous corrosion rate even in 
real time [219].    
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4.2.3.1 Hydrogen Evolution Measurement 
Hydrogen evolution measurements were taken for Mg ring implants from the previous 12 week 
in vivo study or “healing study” as well as SC Mg (Institute of Solid State Physics, Beijing, 
China), uncoated and samples coated (Section 4.2.2) for 2, 5, and 10 minutes (N=2 each). The 
samples were placed in Hanks’ Balanced Salt Solution (Sigma Aldrich, St. Louis, MO) at 37°C.  
The samples were suspended within 1L beaker of HBSS solution underneath an inverted funnel.  
A burette was placed over the top of the funnel above the samples to capture the hydrogen 
released (Figure 16).  All beakers, funnels and burettes were glass to prevent hydrogen 
permeation.  The samples were suspended to ensure full surface exposure and the inverted 
funnels were elevated to prevent ion accumulation within the funnel volume.  The solution level 
in each burette was measured intermittently for 2 weeks.  The corrosion rate can be calculated 
from hydrogen evolution from the following relationship: 
 
where K is 8.76 x 104, W is mass loss (g), A is exposed area (cm2), T is time of exposure (h), and 
D is the density of the material (g/cm3). 
 
where ΔW is change in mass (mg), VH is the volume of hydrogen evolved (mL), and PATM is 
atmospheric pressure. 
To further elucidate the corrosion properties of the Mg ring implant used in the previous 
12 weeks of healing study, change in mass was calculated and microCT images were obtained 
after hydrogen evolution testing. 
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Figure 16: Hydrogen evolution measurement setup 
4.2.3.2 In Vitro Immersion Testing 
In vitro corrosion studies were conducted using HBSS (Sigma Aldrich, St. Louis, MO) as the 
immersion solution (initial pH of 7.4).  The Mg disk samples were placed in 50 mL 
polypropylene tubes (Falcon Blue Max, BD, Franklin Lakes, NJ) with 50 mL of HBSS.  The 
samples were placed inside an incubator which was maintained at 37°C.  The Mg ion 
concentration of the solution, pH of the solution, and mass of the samples were measured daily 
for 7 days and weekly for 4 weeks.    
4.2.4 Coating Characterization  
In order to know how the coating process changes the surface of the Mg substrate, scanning 
electron microscopy (SEM) was used to observe the surface morphology of the Mg substrate.  
The Mg disks were coated with palladium for 90 seconds. Scanning electron microscopy (SEM) 
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(JOEL JSM-6610LV) was used to characterize the surface morphology of the coated surfaces.  
The porosity of the coating was determined from the SEM images using Image J (NIH, 
Bethesda, MD).  
4.2.5 Surface Characterization 
Lastly, the MAO coating changes the surface qualities of the Mg substrate.  The hardness, 
roughness, and hydrophilicity were characterized in order to quantify the changes and give 
insight to the potential cellular response to the MA coating. Vickers microhardness was 
measured using a microindenter (LM800 Microhardness Tester, LECO Corporation, Saint 
Joseph, MI) whereby a sharp indenter tip applied a load of 50 g to the surface of the sample with 
a 10 second dwell time (Figure 17).  The indentation created by the square pyramidal diamond 
indenter was measured using optical microscopy.  The Vickers Pyramid number (HV) was 
determined by F/A, where F is the force applied to the diamond indenter in kilograms-force and 
A is the surface area of the resulting indentation in square millimeters.  A was determined by the 
formula: 
 
where d is the average length of the diagonal length left by the indenter in millimeters.  The HV 
number was then calculated by: 
 
where F is in kgf. 
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Figure 17: Schematic of Vickers Hardness testing 
 
The surface roughness was measured by means of a surface profiler (KLA Tencor, Alpha 
Step IQ) and the average roughness (Ra) was obtained.  Hydrophilicity was quantified using 
contact angle measurements using a tensiometer.  Contact angles were measured with a system 
equipped with a microscope and a camera.  A 5 μl droplet of distilled water was suspended from 
the tip of the microliter syringe.  The syringe tip advanced toward the surface until the droplet 
made contact with the surface.  Images were collected with the camera and the contact angle 
between the drop and the surface was measured by the software. 
4.2.6 Data Analysis 
The porosity, coating thickness, Mg concentration, average roughness, hardness, and contact 
angle were averaged between samples and expressed as a mean ± standard deviation.  Two-way 
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ANOVA was used to compare the values in response to the independent factors, substrate type 
(SC Mg and 99.9% Mg) and coating time (2 and 5 minutes).  Statistical significance was defined 
as p<0.05.  This data was used to identify if there is an ideal material-coating combination that is 
able to achieve the desired corrosion rate with properties most attractive to cellular contact (i.e. 
harder, rougher, more hydrophilic). 
4.3 RESULTS 
4.3.1 Hydrogen Evolution Measurement 
The hydrogen evolution measurement of Mg ring implants from the previous “healing study” 
was obtained (Figure 18).  The glassware for one of the implants broke after 1 week reducing the 
intended time of exposure.  However, the corrosion profiles of both samples were similar.  There 
was minimal corrosion for the first 60 hours.  Then the corrosion increased up to more than 5 mL 
of hydrogen gas.  Table 1 gives the weight before and after the Mg ring implants were immersed 
in HBSS for up to 2 weeks.  There is no change in mass because the physical degradation of the 
Mg ring implants was not greater than the accumulation of corrosion products (Figure 19).  
54 
 
Figure 18: Hydrogen evolution measurements of Mg ring implants (from previous 12 weeks of healing study 
or "Healing Study") immersed in HBSS for 2 weeks  
 
After completion of the hydrogen evolution measurement, microCT images of the 
corroded Mg ring implants were taken and the percent corrosion was quantified.  After 2 weeks 
immersed in HBSS, the microCT images (Figure 20) indicated that the MAO coated Mg ring 
implant degraded 13% compared to the pre-immersion images.  
 
Table 1: Weight of Mg ring implants before and after immersion in HBSS 
Sample Weight (g) Before Immersion Weight (g) After Immersion 
Healing Study a 0.087 0.088 
Healing Study b 0.087 0.085 
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Figure 19: Photographs of the MAO coated Mg ring implants from the previous "healing study" before 
hydrogen evolution measurements (A) and after immersion in HBSS (B&C) 
 
After completion of the hydrogen evolution measurement, microCT images of the 
corroded Mg ring implants were taken and the percent corrosion was quantified.  After 2 weeks 
immersed in HBSS, the microCT images (Figure 20) indicated that the MAO coated Mg ring 
implant degraded 13% compared to the pre-immersion images.  
After completion of the hydrogen evolution measurement, microCT images of the 
corroded Mg ring implants were taken and the percent corrosion was quantified.  After 2 weeks 
immersed in HBSS, the microCT images (Figure 20) indicated that the MAO coated Mg ring 
implant degraded 13% compared to the pre-immersion images.  
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Figure 20: Micro CT reconstruction (A) and cross section (B) of corroded Mg ring implant 
 
The uncoated Mg ring implants and those coated for 2, 5 and 10 minutes underwent 
hydrogen evolution in attempts the match the corrosion profile of the implants from the previous 
“healing study” (Figure 21).  The 2 uncoated samples had similar corrosion profile with fast 
corrosion with an approximate 1 mL of hydrogen gas evolved within the first 60 hours followed 
by minimal to no corrosion for the remaining time of exposure.  For the 2 minute coated 
implants, there was variation between the corrosion profiles of the 2 samples with sample 2 min 
a having more hydrogen gas evolved than the “healing study” samples and sample 2 min b 
having less hydrogen gas evolved.  A similar trend is seen with the 5 minute coated samples with 
sample 5 min a having more hydrogen gas evolved than the “healing study” samples and sample 
5 min b having less hydrogen gas evolved.  The Mg ring implants coated for 10 minutes has less 
hydrogen gas evolved than those of the previous “healing study” as well as those coated for 2 
minutes and 5 minutes excluding sample 5 min b.  The Mg ring implants coated for 2 minutes 
and 5 minutes had hydrogen evolution profiles closest to those of the previous “healing study.”  
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Figure 21: Hydrogen evolution measurement of Mg ring implants from the previous "healing study" as well 
as those uncoated and coated for 2, 5, and 10 minutes 
4.3.2 In Vitro Degradation  
In vitro degradation testing on SC and 99.9% Mg coated for 2 minutes, 5 minutes as well as 
uncoated disks was conducted (Figure 22).  This describes the corrosion of the substrates in 
HBSS for up to 4 weeks.  The Mg ion concentration in the HBSS after immersion of the SC 
samples depicts minimal change in Mg ion concentration over the 4 week time period (Figure 
23).  The uncoated samples had Mg ion concentration greater than the other samples at each time 
point.  There was no significant difference between the Mg ion concentration of the 2 minute and 
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5 minute samples.  A similar trend was seen with the change in pH values of the HBSS solution 
after the Mg disks had been immersed up to 28 days (Figure 24).  The uncoated samples had a 
greater change in pH than the 2 minutes and 5 minute samples while there was no significant 
difference between the change in pH of the 2 minute and 5 minute samples. 
 
 
Figure 22: Photograph of Mg disk sample before and after MAO coating 
 
 
Figure 23: Mg ion concentration (ppm) in HBSS after in vitro corrosion testing of SC Mg disks 
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Figure 24: Change in pH of HBSS after in vitro corrosion testing of SC Mg disks 
 
Lastly, the percent change in mass of the SC samples was recorded (Figure 25).  The 
approximate initial mass of the uncoated SC samples was 0.12 g.  The percent mass of the 
uncoated SC samples increased up to 2%, an estimated 2.4 mg, the first 3 days and didn’t vary 
much the remaining 4 week time period.  There was less than 1% increase in the mass of the 2 
min and 5 minute samples over the 4 week duration.  The percent increase in mass as opposed to 
decrease as a result of corrosion is due to the accumulation of corrosion products with minimal to 
no physical mass loss.   
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Figure 25: Percent change in mass of SC Mg disks after in vitro corrosion testing 
 
The in vitro degradation testing was also performed on the 99.9% Mg as a commercially 
available control (Figure 26).  For the uncoated, 2 minutes, and 5 minute samples, the Mg ion 
concentration steadily increased over the 4 weeks ranging between 2 ppm at 1 day to 10 ppm 
after 4 weeks immersed in HBSS.  The uncoated samples and the 5 minute coated samples had 
comparable Mg ion concentrations up to 2 weeks.  The 2 minutes samples had the least amount 
of Mg ion concentration suggesting a slower corrosion rate.   
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Figure 26: Mg ion concentration (ppm) in HBSS after in vitro corrosion testing of 99.9% Mg disks 
 
A similar trend was seen with the change in pH of the HBSS after the 99.9% Mg samples 
were immersed in HBSS for 4 weeks (Figure 27).  There was a steady increase in the change in 
pH from about 8.4 to 10 (initial pH of HBSS is 7.4).  There was no significant different between 
the change in pH of the uncoated, 2 minute, and 5 minute groups.  The Mg ion concentration and 
change in pH indicate a steady degradation of the samples over 4 weeks of interest. 
Finally, the change in mass of the 99.9% Mg uncoated, 2 minutes, and 5 minutes showed 
an initial increase in mass over the first 1-2 weeks followed by a decrease in mass which is an 
indication that the physical mass loss has become greater than the accumulation of corrosion 
products (Figure 28).  The trend in change in mass was similar to that of the Mg ion 
concentration and change in pH where the 2 minute samples had the slowest corrosion rate. 
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Figure 27: Change in pH of HBSS after in vitro corrosion testing of 99.9% Mg disks 
 
 
Figure 28: Percent change in mass of 99.9% Mg disks after in vitro corrosion testing 
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4.3.3 Surface Morphology 
The SEM images of the uncoated, 2 minute, and 5 minutes samples of SC Mg as well as the 
99.9% Mg control were recorded highlighting the characteristic porous surface of MAO coating 
(Figure 29).  The uncoated samples were not porous.  The porosity of the SC Mg 2 minute and 5 
minute samples were 7.2 ± 3.0 % and 6.5 ± 2.0%, respectively (Table 2).  There was no 
significant difference between the 2 minute and 5 minutes samples as well as between the SC mg 
and 99.9% Mg control samples.  The porosity of the 99.9% Mg 2 minute and 5 minute samples 
were 7.0 ± 3.1 % and 6.9 ± 0.6%, respectively (Table 2). 
 
 
Figure 29: SEM Images (5000X) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 5 minutes 
 
Table 2: Porosity (%) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 5 minutes 
 
 Uncoated 2 min 5 min 
SC Mg ---- 7.2 ± 3.0 6.5 ± 2.0 
99.9% Mg ---- 7.0 ± 3.1 6.9 ± 0.6 
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4.3.4 Hardness  
The Vickers Hardness of the uncoated and coated Mg samples was recorded (Table 3).  The 
hardness of the uncoated, 2 minute, and 5 minute samples of SC Mg was 46 ± 8, 96 ± 14, and 
101 ± 18, respectively.  The hardness of the uncoated, 2 minute, and 5 minute samples of 99.9% 
Mg was 42 ± 2, 83 ± 3, and 90 ± 2, respectively.  There was no significant difference between 
the SC Mg and 99.9% Mg groups.  The MAO coating increased the hardness of the substrate by 
2 times (Figure 30). 
 
Table 3: Hardness (HV) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 5 minutes 
 Uncoated 2 min 5 min 
SC Mg 46 ± 8 96 ± 14  101 ± 18 
99.9% Mg 42 ± 2 83 ± 3 90 ± 2 
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Figure 30: Hardness (HV) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 5 minutes 
4.3.5 Roughness 
The average roughness of the uncoated and coated Mg samples was recorded (Table 4).  The 
average roughness of the uncoated, 2 minute, and 5 minute samples of SC Mg was 133 ± 15 μm, 
320 ± 44 μm, and 510 ± 85 μm, respectively.  The hardness of the uncoated, 2 minute, and 5 
minute samples of 99.9% Mg was 129 ± 29 μm, 226 ± 33 μm, and 513 ± 43 μm, respectively.  
There was no significant difference between the SC Mg and 99.9% Mg groups.  The MAO 
coating increased the roughness of the substrate by approximately 250% for the 2 minute group 
and 400% for the 5 minute group (Figure 31). 
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Table 4: Average roughness (Ra, μm) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 5 minutes 
 Uncoated 2 min 5 min 
SC Mg 133 ± 15 320 ± 44  510 ± 85 
99.9% Mg 129 ± 21 226 ± 33 513 ± 43 
 
 
 
Figure 31: Average roughness (Ra, μm) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 5 
minutes 
4.3.6 Contact Angle Measurement 
The contact angle of the uncoated and coated Mg samples was recorded as an indication of 
hydrophilicity (Figure 32).  The contact angle of the uncoated, 2 minute, and 5 minute samples 
of SC Mg was 62 ± 8, 7 ± 2, and 10 ± 2, respectively (Table 5).  The contact angle of the 
uncoated, 2 minute, and 5 minute samples of 99.9% Mg was 74 ± 7, 11 ± 5, and 29 ± 18, 
respectively.  There was no significant difference between the SC Mg and 99.9% Mg groups.  
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The MAO coating decreased the contact angle for the substrate by approximately 80% for both 
the 2 minute and 5 minute groups; thus, increasing the hydrophilicity (Figure 32). 
 
 
Figure 32: Images of contact angle (in degrees) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 
5 minutes 
 
Table 5: Contact angle (in degrees) of SC Mg and 99.9% Mg disks uncoated and coated for 2 and 5 minutes 
 Uncoated 2 min 5 min 
SC Mg 62 ± 8 7 ± 2  10 ± 2 
99.9% Mg 74 ± 7 11 ± 5 29 ± 18 
 
4.4 DISCUSSION 
In recent years, there has been a renewed interest in the use of Mg for biomedical applications 
because of its mechanical properties and it can be resorbed by the body and replaced by native 
tissue [201, 202].  These properties make it especially promising for a wide range of uses such as 
orthopaedics, cardiovascular, and so on.  However, the specific needs of different applications 
vary making it challenging to optimize an ideal Mg substrate.  Thus, there is vast amount of 
research on engineering the corrosion rate.  Such methods include but are not limited to grain 
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refinement, alloying, and coating.  Further consideration must be given to how the strategies for 
controlling the corrosion rate affect the biocompatibility and mechanical properties. 
For ACL healing, a Mg substrate that could resist corrosion in the early stages (3-6 
weeks) and degrade completely by 12 weeks in vivo was an established goal.  Additionally, a Mg 
substrate with high ductility is especially advantageous for an implant in an articulating joint to 
allow for deformation without damage to the articular cartilage, menisci, and other soft tissues.  
Also, the absence of alloying elements and minimization of defect concentrations as discussed 
above in regards to dislocations and stacking faults was desired to ensure the desired 
biocompatibility and ease of clinical translation.  Thus, a single crystal substrate devoid of any 
alloying elements was selected because the monocrystalline structure allows for greater 
corrosion resistance, and higher ductility. 
In addition to the single crystal Mg substrate, we employed a coating to further resist the 
corrosion at early stages and then allow for complete resorption of the Mg ring implant.  MAO 
deposits a biocompatible coating that is able to yield implant degradation and allow for favorable 
cell interaction.  MAO coating is characterized by a dense layer that resists infiltration in an 
aqueous environment and is beneath a porous layer that is attractive to cells.  The composition of 
the coating is dependent on the electrolytic solution, the porosity of the coating is dependent on 
the applied voltage, and the thickness of the coating is dependent on the coating time.  In 
Specific Aim 1, we aimed to characterize the coating parameters and the resulting coating in 
order to establish a benchmark for future development of the material-coating combination.    
In previous in vivo studies of ECM + Mg ring repair of a transected ACL in a goat model 
at 12 weeks of healing, stifle joints in which the Mg ring implant was resorbed by the endpoint 
had more likelihood of favorable healing.  Contrarily, if the implant was still present after 12 
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weeks of healing, it appeared as though the implant may have been physically blocking the 
healing of the ACL.  Thus, in Specific Aim 1, we aimed to match the in vitro degradation profile 
of a Mg ring implant used in the previous study with favorable results.  The degradation profile 
obtained from hydrogen evolution measurements seemed to be slow during the first 60 hours 
followed by accelerated corrosion.  While we cannot make a direct relationship between the in 
vitro degradation and the potential in vivo degradation, the likelihood that the in vivo result 
would be similar to previous implants is greater if the in vitro degradation is the same.   Thus, 
MAO coating of single crystal Mg for 2 minutes closely matched the in vitro degradation of the 
Mg ring implant from previous studies. However, there was variability of the corrosion rates 
observed within the groups for each coating time which could be indicative that the coating 
method was likely not consistent enough to produce repeatable results.  The methodology for 
MAO coating is not trivial and close attention should be given to the preparation of the 
electrolytic solution, and moreover, the single crystal substrate preparation (i.e. materials purity, 
crystal orientation, machining that tends to result in creation of defects (grain boundaries, 
stacking faults and dislocations, etc.), polishing, temperature during processing, etc.), application 
of voltage, and coating timing in order to get consistent results.  In the same set of hydrogen 
evolution measurements, it appears that the uncoated single crystal degrades slower than the 
coated single crystal Mg.  This is unexpected because it is expected that uncoated Mg will likely 
exhibit rapid corrosion immediately and subsequently, with the formation of a passivation layer 
it is likely that the coating would cause the corrosion rate to be reduced and eventually plateau 
out.  However, it is observed herein that coated Mg degrades exhibiting an opposite trend, 
displaying slow corrosion initially and faster once the coating is no longer effective.  These 
trends are observed in the very early stages of the hydrogen evolution measurements but become 
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questionable over the course of 2 weeks.  It is possible that the coating structure (density, 
distribution of porosity and pore size distribution, adhesion strength) is not consistent enough 
due to the variability in the substrate preparation stage. As a result, a consistent and reproducible 
corrosion resistant layer that is characteristic of MAO coating is not adequately formed during 
the short coating times selected for this study. Thus, the layer formed is likely very porous 
rendering the Mg substrate more susceptible to corrosion as the HBSS was able to infiltrate and 
initiate corrosion.       
In Specific Aim 1, further characterization of the corrosion of MAO coated single crystal 
Mg was conducted with a commercially available 99.9% pure Mg control.  It was shown that the 
single crystal Mg is more resistant to early corrosion than polycrystalline Mg as indicated by Mg 
ion concentration, pH, and mass measurements.  Ultimately, these three measurements should 
provide similar trends on the corrosion rate.  The polycrystalline Mg started degrading within the 
first week and continued throughout the 4 week time period.  Contrarily, the single crystal Mg 
had minimal change in the Mg ion concentration, pH, and mass which indicates minimal 
corrosion.  This further supports the use of MAO coated single crystal for the ACL healing 
application. 
In addition to observing the corrosion of the single crystal Mg, characterization of the 
coating was also done to gain insight to additional advantages of using MAO coating.  The MAO 
coating was more porous, harder, rougher, and more hydrophilic than uncoated single crystal Mg 
and 99.9% Mg.  Each of these parameters provide an environment far more favorable for cellular 
interactions.  Hardness is strongly dependent on the coating thickness, interface strength, and the 
pore size as well as pore size distribution.  Increased hardness results in an increased cell 
proliferation, especially fibroblasts and osteoblasts [233-236].  Similarly, the surface roughness 
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has been shown to increase with coating time and cell attachment is influenced by the roughness 
of the surface.  Cell spreading and differentiation are known to be influenced by both micro scale 
roughness and wettability [237-240].  The contact angle measurement showed that uncoated Mg 
is less hydrophilic than the MAO coated Mg, which supports the common practice of coating 
metallic implants regardless of coating method in order to enhance cell adhesion and 
proliferation [241-243].  Further investigation of these coating and surface properties in 
relationship to cell response could be achieved through a series of cell culture experiments which 
could also help establish acceptable ranges for the parameters of interests. 
There were no significant differences between the two substrates or the coating times.  
Perhaps the differences between coating the substrates for 2 min and 5 min were not pronounced 
enough.  In many published studies, investigators research coating for up to many hours.  
However, they sought to increase the corrosion resistance much more than what is desired for 
ACL healing.   
There are number of unexpected results and limitations of the materials characterization 
step conducted herein.  For example, with the hydrogen evolution measurements, the uncoated 
samples did not seem to corrode faster than the coated samples while the opposite trend was 
observed with the in vitro immersion testing.  However, these non-electrochemical methods for 
determining corrosion rate should provide similar trends from the results.  There are a number of 
varying parameters between the setup and implementation for each testing protocol that could 
have led to these observed discrepancies such as the amount of HBSS used, method of 
temperature control implemented, and so on.  For future studies, it would be advantageous to use 
the same testing parameters across all experiments.  Also, changing the solution daily would also 
give more reliable results as the solution could become saturated by the 2 week and/or 4 week 
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time periods of interest.  Saturation of the solution could yield likely false corrosion rate 
indications and hence, also provide results that deviate from the naturally occurring corrosion 
process.  
The results from the characterization of the coating and surface followed previously 
reported trends in literature.  However, there were minimal differences between the 2 minute and 
5 minute coating times.  In future studies, it might be most beneficial to select coating times with 
a more determined time lapse between them. Also, the contact angle measurements obtained may 
have been misleading as the water droplet seemed to sink into the pores which may also indicate 
that the porosity of the coating layer is variable and an adequately dense layer may not have had 
adequate time to form.  As previously mentioned, this may further explains why in some 
instances the coating seemed to increase the corrosion rate as opposed to slow it as expected.  In 
future studies, cross sectional analysis could be used to determine if both, dense and porous 
layers are present. Additionally, electrochemical evaluation (i.e. potentiodynamic polarization 
(PDP) testing, electrochemical impedance spectroscopy) could provide additional understanding 
of the corrosion properties and the molecular effects of MAO coating [219]. 
Despite these limitations, completion of the characterization of the single crystal Mg and 
99.9% Mg sets a benchmark for the coating parameters of the Mg ring implant.  As the 
development of the ECM + Mg ring repair continues, considerations of how to improve the 
implant can be determined based on these parameters.  For example, if a more porous coating is 
desired, the voltage should be increased.  However, increasing the coating time may not be 
advisable if the other parameters should remain nearly constant.  Also, further establishing a 
desired range for stiffness, ductility, and malleability would be helpful for knowing what 
properties are ideal to avoid damage to the inter-articular structures of the knee.  Ultimately, the 
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MAO coated single crystal substrate was determined to be sufficient for this initial proof of 
concept study. 
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5.0  LONG TERM IN VIVO STUDY OF ECM + MG RING REPAIR FOR 
REGENERATION OF A TRANSECTED ACL IN A GOAT MODEL 
5.1 INTRODUCTION 
As summarized in Section 2.2.6.3, “ECM + Mg-ring repair” combines biological augmentation 
and mechanical augmentation using an extracellular matrix (ECM) sheet and hydrogel along 
with a novel metallic implant made with Mg and shaped like a cylinder, or a Mg ring designed to 
bridge the gap between the two ends of a torn ACL.   
The biological augmentation is provided by ECM.  ECM scaffolds consist of the 
structural and functional molecules secreted by the resident cells of the tissue and organ from 
which they are prepared.  There are numerous advantages to using ECM scaffolds for tissue 
engineering applications.  First, they provide a temporary structural scaffold upon which 
regeneration can occur [244].  Second, rapid degradation of the scaffold results in generation of 
chemotactic and mitogenic cryptic peptides [245-250].  Third, modulation of the innate immune 
response toward repair and regeneration (i.e. M2 profile) has been shown to result from the use 
of ECM scaffolds [251].  Lastly, they recruit multipotential progenitor cells to the site of interest 
[252].  The use of the ECM hydrogel allows for immediate activity to incite healing while the 
ECM sheets permit continuous activity throughout early stages of healing [253]. ECM has been 
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successfully used for the healing of ligaments and tendons including the MCL [254, 255], 
patellar tendon (PT) defect [256], and ACL [19].   
The mechanical augmentation is provided by the Mg ring.  The Mg ring serves to bridge 
the gap between the separate ends of the ACL.  In vivo, it can also help to protect from the 
synovial fluid and restrict destructive motion of the ligament.  Also, the Mg ring can restore 
stability to the knee joint immediately post-operatively and load the healing ligament throughout 
the healing process preventing disuse atrophy of the insertion sites [21, 186].  Additionally, the 
entire ECM + Mg ring repair construct can be resorbed by the body as the healing tissue begins 
to bear load.  It has been shown that mechanical augmentation would stabilize the knee 
immediately after surgery and could work synergistically to help the biological augmentation to 
stimulate and accelerate healing the ACL. 
As a next step, a long-term in vivo study of ECM + Mg ring repair of a transected ACL 
was conducted in a goat model and assessed after 26 weeks of healing.  A total of 14 goats 
underwent ECM + Mg ring repair.  One specimen was designated for histological evaluation 
while the remaining were assessed for joint stability, ligament function, and structural properties.  
The objective was to determine if the success of previous in vivo studies would persist to 26 
week post-operatively as characterized by continuous collagen fibers without atrophy of the 
insertion sites as well as resorption of the implant. 
76 
5.2 METHODS 
5.2.1 Animal Model 
Skeletally mature (4-6 years of age), female Spanish goats were used.  This animal model has a 
large size and robust activity level that make it well-suited for studies of the knee.  Additionally, 
the goat has been successfully used historically in our research center and others for studies of 
ACLR as well as healing of other ligaments and tendons. 
A number of in vivo animal models have been used to investigate healing of ligaments and 
tendons. Rodent models were not frequently used because of their small size making it difficult 
to perform surgical repair accurately. For ACL reconstruction, large animals such as dogs, pigs, 
goats and sheep are preferred.  Based on a comparative study of the stifle joint of a number of 
experimental animals, the goat is a good choice partly because there are large volumes of data in 
the literature that could be used for comparison [187, 257, 258].  
5.2.2 Preparation of Mg Ring Devices 
For in vivo experiments, SC Mg was used due to its known biocompatibility as well as ductility.  
It was machined according to Section 4.2.1.2 and MAO coated according to Section 4.2.2.  
Following the application of the MAO coating, Mg ring devices were sterilized for surgery using 
ethylene oxide. 
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5.2.3 Preparation of ECM Bioscaffolds 
ECM sheets and pre-gel digests from the porcine urinary bladder matrix (UBM) was provided by 
Dr. Badylak’s laboratory.  Well-established protocols were used to prepare the scaffolds from 
urinary bladders of market-weight pigs.  Briefly, the bladders were cut open and the urothelial, 
serosal, and musculolayers were scraped away.  The remaining tissue (basement membrane and 
tunica propria) were treated with a 0.1% peracetic acid/4% ethanol solution and then lyophilized. 
5 x 40 mm sheets were cut and sterilized with ethylene oxide. 
 To prepare the UBM hydrogels, additional lyophilized UBM was powdered using 
a Wiley Mill and filtered through a 40 mesh screen.  Then, the UBM powder was enzymatically 
digested under continuous stirring using 1 mg/ml pepsin in 0.01 M HCl for 72 hours, and the 
resulting pre-gel digest (10 mg ECM/ml (dry weight)) was frozen at -20°C.  On the day of 
surgery, the pre-gel digest was thawed in 2.5 ml aliquots during the operation, and neutralized by 
adding one-tenth volume of 0.1 M NaOH, one-ninth the volume of 10X PBS, and then diluting 
to a final concentration of 6 gm/ml using 1X PBS.  The hydrogel was passed through a sterile 
filter and stored on ice until injection in vivo. 
5.2.4 Surgical Procedure 
The surgical protocol was approved by the University of Pittsburgh’s Institutional Animal Care 
and Use Committee (IACUC).  All procedures were performed with sterile techniques using 
general endotracheal anesthesia.  In all animals, the ECM + Mg ring repair was performed on the 
right stifle joint and the left served as a sham-operated control. 
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 A longitudinal incision was made on the midline of the stifle joint from 1-2 cm 
above the patella to just below the tibial insertion of the patellar tendon.  Then, an arthrotomy 
was performed medially to the patellar tendon, such that the patellar tendon could be minimally 
retracted in the lateral direction and the ACL exposed (Figure 33).  With clear visualization of 
the ACL, four bone tunnels were drilled in the femur and tibia using a 1.5 mm guide wire.  On 
the tibial side, tunnels were made medial and lateral to the ACL’s insertion, while on the femoral 
side, two parallel tunnels were made anterior to the insertion.  Then, two sets of “repair sutures” 
(Vicryl 2-0, Ethicon) and “fixation sutures” (Ethibond Excel #2, Ethicon) were attached to each 
end of the transected ACL.  Then, the Mg ring implant was attached to the ACL with the repair 
sutures passing directly through the ring and tied around it.  The fixation sutures were passed 
through the suture holes and bone tunnels and fixed on the outside of the bones using a knot tied 
over an Endobutton on the femoral side (Smith & Nephew, Andover, MA) and a double-spiked 
plate and fixation post on the tibial side (Smith & Nephew, Andover, MA) (Figure 5B).  Before 
femoral and tibial fixation outside the bone tunnels, the 5 x 40 mm UBM sheet sutured to a 
similarly-sized fibrin sponge (Surgifoam, Ethicon, Inc., Bridgewater, NJ) was wrapped around 
the Mg ring implant.  After fixation of the Mg ring, additional UBM hydrogel (~4 ml) was 
injected directly into the injury site.  A local analgesic (Bupivacaine, 1 mg/kg) was injected 
subcutaneously, and the wounds were closed.   
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Figure 33: Medial incision and visualization of the ACL 
5.2.5 Post-Operative Care 
Following surgery, the animals were allowed free cage activity.  For pain management, 
Banamine was administered twice daily subcutaneously (1.1 mg/kg) for 6 days post-surgery, and 
Metacam was administered every 3-5 days subsequently as deemed necessary by the animal 
facility veterinarian.  Animals were assessed daily for general health and the weight bearing 
status of the treated joint.  A scale was used for qualitative assessment of lameness (Table 6).  At 
the 4, 5, and 6 month time points, manual anterior drawer exams were conducted under twilight 
sedation (5 mg/kg Ketamine) to assess ACL functionality throughout healing using a qualitative 
scale (Table 7).  Furthermore, x-rays of the ECM + Mg ring repaired joint were taken to observe 
the presence of the Mg ring implant as well as any abnormalities such as joint space narrowing. 
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Table 6: Lameness scoring scale 
Score Weight-bearing status 
0 Three-legged walking 
1 Clear walking lameness/toe-touching 
2 Mild walking lameness, clear during running 
3 Minimal running lameness 
4 Normal 
 
At the end point of the study (26 weeks), animals were humanely euthanized.  They were 
first sedated using an intramuscular injection of Ketamine/Xylazine (7 mg/kg Ketamine, 0.1 
mg/kg Xylazine), followed by a lethal injection of sodium pentobarbital (1 mg (390 mg)/10 lbs).  
Both treated and sham-operated legs were harvested using a scalpel by disarticulation of the hip 
joint.  Of the harvested joints (N=24, 12 goats at the study endpoint), two joints were used for 
histology and the remaining joint specimen were used for biomechanical evaluation. 
 
Table 7: Qualitative scale for the anterior drawer exam 
Score Description 
A Normal • No or very little anterior translation of the tibia 
• Less than 3 mm 
B Near Normal • Little anterior translation of the tibia with a firm endpoint 
• Less than 5 mm 
C Abnormal • More anterior translation of the tibia with a firm endpoint 
• More than 5 mm 
D ACL Deficient • A lot of anterior translation of the tibia with no endpoint 
• More than 10 mm 
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5.2.6 Gross Morphology 
The gross morphology of the healing ACL was assessed following the dissection of the femur-
ACL-tibia complex (FATC).  The size, shape, color, alignment, and continuity of the healing 
tissue were recorded.  The articulating surfaces of the patella and the femoral condyles were 
inspected for the presence of chondral lesions, and the healing of the bone tunnels was also 
assessed.  Degradation of the Mg ring implant as well as the presence of the fibrin sponge and 
ECM sheet were noted. 
5.2.7 Histological Evaluation 
In the stifle joints designated for histological evaluation (N=2, an experimental and a 
contralateral sham operated control), the FATC was dissected and trimmed immediately after 
harvest.  It was submerged in 10% neutral-buffered formalin (Sigma Aldrich, St. Louis, MO) for 
48 hours and then stored in 70% ethanol prior to histology.  Histology was performed at Alizee 
Pathology, LLC (Thurmont, MD).  The treated FATC was embedded in methylmethacralate 
(MMA) and the sham-operated FATC was embedded in an oversized paraffin block after 
decalcification.  Then, the samples were sectioned sagittally to generate three serial sections that 
were ground, polished, and stained with hematoxylin and eosin (H&E), Stevenel’s Blue (SB) and 
Herovici stain.  The Herovici staining was used to determine collagen type and maturity [259].  
The sections were evaluated using light microscopy. 
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5.2.8 Analysis of Synovial Fluid 
Approximately 1 ml samples of synovial fluid were collected from the treated and sham-operated 
stifle joints immediately after sacrifice using an 18-guage needed.  A small amount (~100-200 
μl) of each sample was used to smear a glass slide, and the JorVet Dip Quick Stain (Jorgensen 
Laboratories, Inc., Loveland, CO) was used to qualitatively assess cytology.  After air drying the 
prepared slide, it was dipped into methanol for fixation, followed by polychromatic stains (eosin 
and thiazine) to allow detection and visualization of nucleic acids, protein eosinophil granules, 
and mast cell and basophil granules.  Once prepared, the slides were observed under light 
microscopy.  Additionally, the total protein content was measured using a refractometer. 
5.2.9 Robotic Testing 
The robotic manipulator has a position and orientation repeatability of 0.2 mm and 0.2°, 
respectively.  This testing system can be operated in force control mode to measure the 6 DOF 
joint kinematics in response to externally applied loads.  It can also be used in position control 
mode to repeat previously recorded 6 DOF kinematics such that the in-situ forces in ligaments 
and other soft tissue structures can be determined to within a few Newtons of accuracy [260-
262].  For the past twenty years, the robotic/ UFS testing system has been successfully used to 
accurately determine the multiple DOF (translations and rotations) of knee joints as well as in-
situ forces of soft tissues in response to externally applied loads when the knee undergoes 
unrestricted motion. 
The robotic/UFS testing system was used to assess joint stability and the in-situ forces in 
the healing ACL upon external loads (N=20, 10 experimental and 10 contralateral sham operated 
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control).  The UFS system (Model Theta; ATI Industrial Automation, Apex, North Carolina, 
USA) has a capacity of 1500 N of force and 240 Nm of torque and can measure 3 forces and 3 
moments in a Cartesian coordinate system fixed with respect to the sensor with repeatability of 
0.5 N for force and 0.05 Nm for torque.  The robotic manipulator (KUKA Model KR 210; 
KUKA Robotics Corp., Shelby Township, Michigan, USA) is capable of recording and 
reproducing the relative positions between the femur and tibia in the 3-dimensional space with an 
accuracy of less than 0.1 mm and 0.1° with full 6-DOF of motion.  For this study, the 
robotic/UFS testing system was operated in force, position, and hybrid control to obtain joint 
kinematics of the repaired stifle joint as well as the forces carried by the healing ACL.     
The goat stifle joint was thawed at room temperature the day before testing.  Then, it was 
prepared for testing by cutting the femur and tibia about 20 mm from the joint line, and removing 
soft tissues approximately 10 mm away from the joint line, such that the femur and tibia were 
potted in a cylindrical epoxy mold (Everglass, Evercoat, Cincinnati, OH).  Then, the specimen 
was mounted onto the robotic/UFS testing system (Figure 34).  The path of passive flexion-
extension was determined by flexing the joint at 1° increments, finding the position that 
minimizes the resulting forces and moments.  This path provided the starting position at each 
angle of flexion for the application of external loads for the remainder of the test and served as 
the reference position by which to measure knee kinematics.  The stifle joint was subjected to (1) 
67 N anterior-posterior load and (2) 5 Nm varus-valgus moment (force control).  The resulting 
kinematics including anterior-posterior tibial translation (APTT) of the stifle joint were measured 
at 30°, 60°, and 90° of joint flexion.  The intact kinematics were replayed for the FATC (position 
control) as each of the following knee structures were removed: medial collateral ligament 
(MCL), soft tissue and lateral collateral ligament (LCL), medial meniscus, lateral meniscus, 
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posterior cruciate ligament (PCL), and bony contact.  The corresponding in-situ force in each 
structure in the joint were calculated using the principle of superposition and the final set of 
forces measured with only the FATC represents the in-situ forces in the ACL. The cross 
sectional area (CSA) and shape of the ACL were measured quantitatively using a laser 
reflectance system developed in our research center [66].   
 
 
Figure 34: Schematic of the robotic UFS testing system [84]  
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5.2.10 Tensile Testing 
After testing on the robotic/UFS testing system, uniaxial tensile testing was performed on each 
FATC to determine its structural properties.  The FATC was mounted to a materials testing 
machine (Model 4052, Instron, Canton, MA) in custom clamps such that the ACL was aligned 
anatomically in its natural direction of tensile loading (Figure 35).  Then, it was preloaded to 3N, 
and the gauge length will be reset.  Then, it underwent cyclic preconditioning between 0 – 1 mm 
of elongation, which is in the toe region of the long-elongation curve, for 10 cycles, at a 
crosshead speed of 50 mm/min.  Finally, the 3 N preload was reapplied and the FATC was 
loaded to failure at the crosshead speed of 10 mm/min.  From the resulting load-elongation 
curve, the structural properties of the FATC were determined, including the stiffness, ultimate 
load, and ultimate elongation. 
 
 
Figure 35: Photograph of set-up of the materials testing machine 
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5.2.11 Data Analysis 
For the in vivo evaluation at 26 weeks of healing, a two-way ANOVA was used to analyze the 
results from the robotic/UFS testing system including APTT and in-situ forces of the ACL. For 
the data from the tensile testing following the robotic testing including stiffness, ultimate load, 
and ultimate elongation, student’s t-test was performed to compare the treated and sham-
operated specimen.  Statistical significance was defined as p<0.05. 
5.3 RESULTS 
All goats were mobile and weight-bearing on the treated joints by 2 hours post-operatively.  The 
goats were housed individually for the first 2 weeks to limit motion and reduce the likelihood of 
injury.  During the course of the study, two goats were euthanized before the end point.  The first 
experienced a broken tibia during recovery (ET# 913) and the second had unsatisfactory 
recovery and was removed from the study at 12 weeks (ET# 891).  The remaining 12 goats 
recovered well.  However, Goat ET#914 was excluded from testing as a result of poor scoring 
during the series of manual AP exams which was indicative of failure.    
5.3.1 Post-Operative Drawer Scores and X-Rays  
For the first 6 weeks, the site of surgery was vulnerable and the goats exhibited lameness during 
walking and running.  By 12 weeks, the goats had normal gait with no evidence of limping 
during walking or running. Thus, the lameness scoring system was used as an indication of 
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recovery but could not be used to determine the quality of the ACL healing.  The anterior drawer 
exam was employed as a qualitative assessment of the ligament function throughout the second 
half of the in vivo study.  Less motion of the tibia was an indication of better healing (Table 7).  
The + and – were added to the score as an indication of the variation between the specimen.  The 
orthopaedic surgical fellow provided a score for the anterior motion of the tibia with respect to 
the femur (Table 8).  Eight of the 12 goats’ scores were near normal (score of B or better) at 4 
months.  By the study endpoint, only 2 remained near normal while the remaining 10 had 
anterior drawer motion large enough to be considered abnormal. 
 
Table 8: Manual anterior drawer exam results, scores with an asterisks were taken at the 3 month time point 
Goat ET# 4 months 5 months 6 months Implant Visible 
(X-Ray)? 
895 B+ C+ C Yes 
896 C C+ C- No 
869 B- B B No 
863 B B+ C No 
904 B+ B+ C Yes 
906 C B- C Yes 
882 B B+ B No 
902 B+ B C Yes 
881 C B- C No 
900 B* B- C No 
903 A* C C- No 
914 C C+ C Yes 
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At the same time the anterior drawer exam was performed, x-ray images were taken of 
the ECM + Mg ring repaired joint.  The presence of the Mg ring implant was noted as well as 
any radiographic evidence of joint abnormalities such as joint narrowing and osteoarthritis.  
Seven of the x-ray images showed no evidence of the Mg ring implant by 6 months (26 weeks).  
Thus, the Mg implant had degraded into very small fragments not detectable by x-ray or 
completely in those stifle joints.   
At 4 months, it seemed as though there was a relationship between the presence of the 
ring and the anterior drawer score suggesting that if the ring is not present, the anterior drawer 
score was be favorable and vice versa.  However, by the endpoint that relationship is not 
sustained.  Goat ET# 895 is an example of a stifle joint with no radiographic evidence of the Mg 
ring implant that had a favorable score at 4 months and by the endpoint the score is abnormal 
(Figure 36).  There is also evident of potential joint narrowing. Goat ET# 895 was used for 
histological analysis.   
 
 
Figure 36: Radiographs of goat ET# 895 after 26 weeks of healing; Anterior-Posterior view (A) and Medial-
Lateral view (B)   
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5.3.2 Gross Morphology of the Healing ACL 
After 26 weeks of healing, the stifle joints were found to be stable upon manual manipulations.  
There were no signs of swelling of inflammation.  The gross anatomical observation of the 
healing ACL showed a variation of the healing ACL.  Most specimen were robustly healed 
ligaments that were mostly white and opaque in color (Figure 37).  Others were not as robust 
with the primary structure of the ACL being composed of the nonresorbable fixation sutures.  
The geometry of the healing ACL was oblong in shape and was slightly hypertrophic.  The 
cross-sectional areas determined by the laser reflectance system was increased from 33 ± 15 mm2 
in the sham-operated ACL to 59 ± 26 mm2 in the healing ACL (Figure 38).  However, the 
difference was not statistically significant.  Visual inspection of the articular cartilage showed no 
evidence of degenerative defects.  There were very small remnants of the Mg ring remaining in 
seven of the 10 specimen located in varying locations within the ACL and surrounding tissue.  
No adverse effects seemed to result from the presence of the remnants. 
 
 
Figure 37: The sham-operated ACL (A) and ECM + Mg ring repaired ACLs with robust neo-tissue (B)  
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Figure 38: Cross-sectional area of sham and ECM + Mg ring repair ACLs 
5.3.3 Histological Evaluation 
The histology of the sham-operated ACL was found to be within normal limits with no evidence 
of inflammation, fibrosis, or synovial hyperplasia noted.  The healing FATC was effectively 
repaired and healed with fibrous connective tissue and a low-grade foreign body reaction to the 
presence of the suture material and remaining Mg material as evident by the H&E (Figure 39) 
and SB (Figure 40) stains.  The transected ends of the ACL were not readily discernable due to 
the fibrous tissue present.  The bone tunnel sites on both the femur and tibia contained suture 
material with a mild foreign body reaction and fibrosis.  Additionally, the tibial insertion site 
contained a small amount of chondrocyte metaplasia that lined the edges and occasionally the 
center of the suture material (Figure 41A). 
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Figure 39: H&E staining of the healing FATC where the dotted line outlines the ACL, the arrow 
points to the femoral bone tunnel containing suture material and the arrowheads show small remnants of Mg  
 
A small amount of Mg ring was found on the H&E slide (Figure 39) and a larger amount 
of Mg ring material was evident on the SB slides (Figure 40).  The Mg ring material was 
surrounded by low numbers of macrophages (low grade foreign body reaction) and a moderate 
amount of dense fibrous connective tissue.  Occasionally, small aggregates of clear space were 
noted within the fibrous connective tissue in the ACL midsubstance.  Within the layer of 
inflammation surrounding one aggregate of clear space was an area with multiple small particles 
of mineralization (Figure 41B).  The black aggregates of Mg material appeared to be surrounded 
by several layers of mineralization as well (Figure 41C).  The synovium was within normal 
limits without evidence of synovial hyperplasia or inflammation. 
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Figure 40: SB staining of the healing FATC where the dotted line outlines the ACL, the arrow points 
to the tibial bone tunnel containing suture material and the arrowheads show small remnants of Mg 
 
 
Figure 41: Small amount of chondrocyte metaplasia lining edges of suture material (A), small 
particles of mineralization within the aggregates of clear space located in the ACL midsubstance (B), and 
minimal inflammatory response composed of low numbers of macrophages surrounding Mg remnants (C) 
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As a result of Herovici staining, the PCL (indicated as an asterisk in Figure 42) stained 
dark purple-blue which is indicative of mature collagen.  In contrast, the fibrous connective 
tissue throughout the ACL stained light blue-green-yellow representing immature collagen with 
occasional areas of darker blue-purple-red staining surrounding the suture material (Figure 42).  
The collagen surrounding the Mg remnants was light yellow-green-blue.  
 
 
Figure 42: Herovici staining of the healing FATC with dotted lines highlighting the edge of fibrous 
connective tissue surrounding the ACL 
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5.3.4 Cytology and Total Protein Content of Synovial Fluid 
The synovial fluids in the sham-operated and healing stifle joints were clear with a sticky 
consistency.  There was no visual difference between the 2 samples. However, the synovial fluid 
was easier to collect from the healing joints and in greater volume.  Similarly, the cytology of the 
synovial fluid from the sham-operated and healing joints were similar.  In both groups, there was 
low cellularity.  However, the synovial fluid from the healing joint had slightly higher synovial 
cells as well as few macrophages.  There were no signs of infection. 
The total protein content in the synovial fluid from the sham-operated joints was 2.0 ± 
0.2 g/dl, which was similar to the value of the value of 2.4 g/dl estimated for normal joint 
synovial fluid in goats (one-third of the total blood serum protein content) (Figure 43) [263].  
The total protein content in the synovial fluid from the healing joints was 2.5 ± 0.4 g/dl.  There 
was not significant difference between the two groups. 
 
 
Figure 43: Total protein content in synovial fluid from sham-operated and healing goat stifle joints after 26 
weeks of healing 
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5.3.5 Joint Stability and In Situ Forces 
The curves representing the average APTT in the sham-operated and ECM + Mg ring repaired 
stifle joints is shown in Figure 44.  Results at 30° of joint flexion are shown as the results were 
similar at all tested joint flexion angles.  In the graph, elongation begins at the point of maximum 
posterior tibial translation and continues to the point of maximum anterior tibial translation.  The 
posterior tibial translation in response to the 67-N posterior tibial load was similar between 
groups because the PCL left intact in both groups.  The curve for the sham-operated group 
continued with a near linear slope through the application of the 67-N anterior tibial load.  
However, near the neutral position (~30 N posterior tibial load), the ECM + Mg ring repaired 
joint became less stable and began to experience higher translation in response to small increases 
in loading.  The continued until 20 N of anterior tibial loading after which joint structures were 
engaged to prevent further translation. 
The APTT in response to the 67-N anterior-posterior tibial load is shown in Table 9.  For 
both the sham-operated and ECM + Mg ring repaired joints, The APTT increased from 30° to 
60° of stifle joint flexion, then decreased at 90°.  The APTT in the sham-operated group ranged 
from 3.3 to 3.8 mm, and was within the range of previously reported values for a normal goat 
stifle joint.  At all flexion angles, the APTT in the ECM + Mg ring repaired joint was about 2.5 
times that in the sham-operated joint. 
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Figure 44: Average curves for the elongation in the sham-operated and ECM + Mg ring repaired 
joints at 30° of joint flexion under 67 N anterior tibial load 
 
The in-situ forces in the ECM + Mg ring repaired ACL in response to the 67-N anterior-
posterior tibial load is also shown in Table 9.  The in-situ force in the ACL in the sham-operated 
joint was close to the applied load and ranged from 56 to 70 N.  The in-situ force in the ECM + 
Mg ring repaired ACL was close to that of the sham-operated ACL at 30° of flexion, and 
decrease by approximately 20 N at 60° of flexion.  At 90° of joint flexion, the in-situ force in the 
ECM + Mg ring repaired ACL decreased again by approximately 40 N.  
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Table 9: Anterior-posterior tibial translation (A) and in-situ forces in the ACL (B) of the sham-
operated and ECM + Mg ring repaired goat stifle joints at 30°, 60°, and 90° of joint flexion 
 
  
To better understand the differences between the function of the sham-operated and ECM 
+ Mg ring repaired joints, the in-situ forces in the other structures in the knee were compared 
(Figure 45).  The force distribution differed between the groups as well as based on the flexion 
angle.  At 30° of joint flexion, the majority of the in-situ force in response to 67-N anterior-
posterior tibial load was in the ACL in both the sham-operated and ECM + Mg ring repaired 
groups.  In the sham-operated joints, there were also smaller forces in the lateral meniscus ( ~40 
N) and bony contact (~30 N), but in the ECM + Mg ring repaired joints the forces shifted to the 
medial meniscus (~40 N).  At 60° of joint flexion, the majority of force in the sham-operated 
group was also carried by the ACL, and the forces carried by the lateral meniscus decreased by 
half and that of the bony contact remained approximately the same.  In contrast, in the ECM + 
Mg ring repaired joints, the in-situ force in the ACL was decreased, with forces also carried by 
the medial meniscus.  Finally, at 90° of flexion, the in-situ forces in the sham-operated joints 
were also carried mostly by the ACL, with smaller forces carried by the MCL and medial 
meniscus.  Alternatively, in the ECM + Mg ring repaired joints, the ACL carried much smaller 
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forces while the other joint structures carried equal or higher forces including the MCL, soft 
tissue, and medial meniscus. 
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Figure 45: In-situ forces in the MCL, soft tissue, medial meniscus, lateral meniscus, bony contact, and ACL in 
the sham-operated and ECM + Mg ring repaired goat stifle joints at 30° (A), 60° (B), and 90° (C) of joint 
flexion 
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5.3.6 Tensile Properties 
The load-elongation curve for the sham-operated and ECM + Mg ring repaired FATCs were 
obtained from the uniaxial tensile testing and were characterized by the toe region followed by a 
linear region prior to failure.  The structural properties of the FATC are shown in Table 10.  The 
stiffness values of the ECM + Mg ring repaired FATCs ranged between 30 and 129 N/mm with 
an average stiffness of about 50% of that of the sham-operated group.  The average ultimate load 
was about 30% of the sham-operated group.  The maximum ultimate load obtained was 981 N 
which is 75 % of the average ultimate load of the sham-operated group.  The average ultimate 
elongation in the ECM + Mg ring repaired group was about 60% of the sham-operated group.   
 
Table 10: Structural properties of the sham-operated and ECM + Mg ring repaired joints 
 
 
After loading the FATCs to failure, the failure mode was noted.  The ECM + Mg ring 
repaired FATCs failed in the ligament midsubstance in 6 out of 10 specimen whereas the others 
failed at the insertion sites.  Figure 46 illustrates the midsubstance failure of the healing ACL. 
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Figure 46: Failure mode of 60% of the specimen was at the midsubstance of the healing ACL 
5.3.7 Time Course Comparison of ECM + Mg Ring Repair  
To further highlight the advantages of ECM + Mg ring repair, the gross morphology, joint 
kinematics, in-situ forces in the healing ACL, and tensile properties were compared at time-zero 
and after 12 and 26 weeks of healing.  Figure 47 shows the gross morphology of Mg ring repair 
at time-zero and ECM + Mg ring repaired ACLs after 6, 12, and 26 weeks of healing.  At time-
zero, the transected end of the ACL are held together by the Mg ring and sutures.  After 6 weeks 
of healing, the Mg ring started to degrade and had fractured.  Neo tissue was observed and there 
was a very small gap (~1 mm) between the transected ends [264].  At 12 weeks of healing, 
complete resorption of the Mg ring was observed in most specimen and there was continuous 
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tissue with no evidence of the initial transection.  Similar results were observed at 26 weeks of 
healing.  It is important to note that the healing results varied after 12 and 26 weeks of healing. 
 
 
Figure 47: Gross morphology of ECM + Mg ring repair at time- zero (A) and after 6 weeks (B), 12 
weeks (C) and 26 weeks of healing (D) 
 
To compare the quantitative values of various studies, values were normalized by the 
sham-operated control values (experimental/control or e/c) in order to reduce interspecimen 
variability.  Figure 48 illustrates the normalized APTT of ECM + Mg ring repair at time-zero and 
after 12 and 26 weeks of healing.  At time-zero, the normalized APTT was about 1.5 at all 
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flexion angles.  The APTT ranged between 2 and 3 times that of the sham-operated control after 
12 weeks of healing and a similar trend was maintained up to 26 weeks of healing. 
 
 
Figure 48: Normalized APTT (e/c) of ECM + Mg ring repair at time-zero and after 12 and 26 weeks 
of healing at 30°, 60°, and 90° of joint flexion 
 
Figure 49 illustrates the normalized in-situ force of ECM + Mg ring repair at time-zero 
and after 12 and 26 weeks of healing.  At 30° of flexion, the in-situ force of the ACL was near 
that of the sham-operated control at time-zero and after 12 and 26 weeks of healing.  The 
normalized in-situ force of approximately 1 was maintained at 60° and 90° of joint flexion at 
time-zero.  Contrarily, the normalized in-situ force decreased from 30° to 60° of flexion, and 
further decreased from 60° to 90° of joint flexion for ECM + Mg ring repaired ACLs after both 
12 and 26 weeks of healing. 
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Figure 50 illustrates the normalized structural properties.  At time-zero, both the stiffness 
and ultimate load were about 20% of the intact joint.  After 12 weeks of healing the normalized 
stiffness was 0.6 and the normalized ultimate load was 0.4.  These values were maintained up to 
26 weeks of healing. 
 
 
Figure 49: Normalized in-situ force (e/c) of ECM + Mg ring repair at time-zero and after 12 and 26 
weeks of healing at 30°, 60°, and 90° of joint flexion 
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Figure 50: Normalized stiffness and ultimate load (e/c) of ECM + Mg ring repair at time-zero and 
after 12 and 26 weeks of healing 
5.3.8 Comparison to Previous ACL Studies 
To further assess the advantages of ECM + Mg ring repair, the time course of the tensile 
properties were compared to that of ACLR in the rabbit [265], canine [266], and goat [187] 
models as well as ACL healing by ECM only treatment in the goat model [19].  Table 11 is a 
compilation of the stiffness of experimental and control joints in the aforementioned animal 
models up to 1 year post-operatively.  The normalized stiffness of the reconstructed ACL in the 
rabbit model was 15% at time-zero, 11% at 6 weeks, 24% at 26 weeks, and 13% at 52 weeks.  
ACLR in the canine model resulted in a normalized stiffness that reached 22% after 1 year.  In 
the goat model, the normalized stiffness of the reconstructed ACL was 12% at time-zero, 13% at 
6 weeks, 12% at 12 weeks, and increased to 21% by 26 weeks and 35% by 52 weeks.  ECM only 
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treatment in the goat model resulted in a normalized stiffness of 47% at 12 weeks and 63% at 26 
weeks.  Similarly, the normalized stiffness of ECM + Mg ring repaired ACL was 24% at time-
zero and increased to 46% by 12 weeks and was maintained to 51% at 26 weeks of healing.  
These results show that the healing approaches reached stiffness values closer to the sham-
operated control faster than ACLR. 
Table 12 is a compilation of the ultimate load of experimental and control joints in the 
aforementioned animal models up to 1 year post-operatively.  The normalized ultimate load of 
the reconstructed ACL in the rabbit model was 7% at time-zero, 7% at 6 weeks, 15% at 26 
weeks, and 11% at 52 weeks.  ACLR in the canine model resulted in a normalized ultimate load 
that reached 16% after 1 year.  In the goat model, the normalized ultimate load of the 
reconstructed ACL was 11% at time-zero, 17% at 6 weeks, 17% at 12 weeks, 17% by 26 weeks 
and increased to 31% by 52 weeks.  ECM only treatment in the goat model resulted in a 
normalized ultimate load of 15% at 12 weeks and 15% at 26 weeks.  Finally, the normalized 
ultimate load of ECM + Mg ring repaired ACL was 15% at time-zero and increased to 25% by 
12 weeks and was maintained to 30% at 26 weeks of healing.  These results show that the ECM 
+ Mg ring repair approach reached ultimate load values closer to the sham-operated control 
faster than the others. 
Lastly, the normalized tensile properties for ACLR and ECM + Mg ring repair in a goat 
model after 26 weeks of healing are shown in Figure 51.  The normalized stiffness of the ECM + 
Mg ring repaired ACL was approximately 10% greater than that of the reconstructed ACL in the 
same animal model.  An even greater difference was seen from the normalized ultimate load with 
the ECM + Mg ring repaired ACL more than twice that of the reconstructed ACL.  These trends 
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are especially interesting as they show that ECM + Mg ring repair is able to reach values better 
than ACLR which is the gold standard for treatment of ACL injuries.  
 
 
Figure 51: Normalized stiffness and ultimate load of ACLR and ECM + Mg ring repair after 26 
weeks of healing in a goat model 
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Table 11: Stiffness of reconstructed or repaired ACLs in various animal models up to 1 year post-operatively 
        Post-Operative Timing (Weeks) 
        0 6 12 26/30 52 
ACL – Rabbit [265]  
e      
c      
e/c 15% 11%  24% 13% 
  
ACLR – Canine [266] 
e     45 ± 19 
c     202 ± 41 
e/c     22% 
  
ACLR – Goat [187] 
e 36 ± 15 39 ± 18 37 ± 22 66 ± 24 108 ± 51 
c 306 ± 67 306 ± 67 306 ± 67 306 ± 67 306 ± 67 
e/c 12% 13% 12% 21% 35% 
  
ECM Treatment – Goat [19] 
e   53 ± 19 71 ± 9  
c   112 ± 21 112 ± 2  
e/c   47% 63%  
  
ECM + Mg ring repair – 
Goat [264] 
e 22 ± 5  59 ± 38 64 ± 33  
c 92 ± 27  127 ± 21 124 ± 19  
e/c 24%   46% 51%   
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Table 12: Ultimate Load of reconstructed or repaired ACLs in various animal models up to 1 year post-operatively 
        Post-Operative Timing (Weeks) 
        0 6 12 26/30 52 
ACL – Rabbit [265] 
e 26 ± 5 22 ± 4  63 ± 19 51 ± 6 
c      
e/c 7% 7%  15% 11% 
  
ACLR – Canine [266] 
e     304 ± 223 
c     1867 ± 324 
e/c     16% 
  
ACLR – Goat [187] 
e 165 ± 68 268 ± 77 269 ± 176 260 ± 71 486 ± 236 
c 1547 ± 464 1547 ± 464 1547 ± 464 1547 ± 464 1547 ± 464 
e/c 11% 17% 17% 17% 31% 
  
ECM Treatment – Goat [19] 
e   249 ± 129 266 ± 28  
c   1624 ± 235 1820 ± 290  
e/c   15% 15%  
  
ECM + Mg ring repair – 
Goat [264] 
e 166 ± 41  287 ± 227 390 ± 265  
c 1144 ± 282  1137 ± 320 1309 ± 164  
e/c 15%   25% 30%   
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5.4 DISCUSSION 
With a Mg ring implant having acceptable corrosion properties for ACL healing, ECM + Mg 
ring repair of a transected ACL was performed in a goat model and assessed after 26 weeks of 
healing.  The overall goal of the in vivo study was to determine if the success of the previous in 
vivo study would persist for 26 weeks.  The healed ACL was assessed by observing the gross 
morphology, joint stability, ligament function and structural properties. 
After implantation of the Mg ring in vivo, the goats recovered very well which could be 
attributed to minimal incision through which to perform the surgery.  This increased the 
difficulty of the surgical procedure.  However, there were limited adverse events after surgery.  
The goats were actually walking and running with no evidence of a pain or limping by 12 weeks.  
Therefore, the lameness scores could not be used as an indicator of the quality of the healing.  In 
order to gauge the progress of the healing throughout the study, the orthopaedic surgery resident 
performed anterior drawer tests at 4 months, 5 months, and 6 months post operatively.  Over the 
course of those three months, the anterior drawer scores seemed to get worse, moving from near 
normal to abnormal.  This was not evident of poor healing.  However, it may suggest that the 
repair construct remains strong at the earlier time points.  By the end point, there may have been 
suture elongation as well as elongation of the healing ligament.  The use of x-rays to visualize 
the Mg ring implant was also employed.  It was very difficult to visualize if the implant was 
present.  But, the x-rays provided confidence that the Mg ring implant has been mostly resorbed 
which had been shown to be beneficial for allowing the ligament to heal.    
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Prior to dissection, analysis of the synovial fluid suggested there was no evidence of 
inflammation.  The total protein content and cytology of the synovial fluid was near normal and 
improved compared to previous 12 week of healing studies [264].  In terms of gross morphology, 
there was continuous new tissue formation after 26 weeks of healing in all samples.  The cross 
sectional area of the healed ACL was slightly hypertrophic.  Noticeably, there was variation 
between specimen.  The results varied between having robust tissue to being mostly the lingering 
fixation sutures with translucent tissue.  Nonetheless, ECM + Mg ring repair successfully healed 
the transected ACL.  This was confirmed by the histological evaluation where the transected 
ends of the ACL were not detectable.  Additionally, Herovici staining was used as an indicator of 
the maturity of the collagen.  The results showed that the entire length of the ACL appeared to 
have immature collagen.  Thus was unexpected as it was thought that the ACL stumps would 
appear to have mature collagen with a gradient to immature collagen at the transection site.  It is 
thought that the tissue that underwent Herovici staining was from the fibrous connective tissue 
that formed around the ACL as opposed to the midsubstance of healing ACL.  Thus, future 
histology of ECM + Mg ring repair should employ Herovici staining of the appropriate region of 
interest observe the maturity of the healing tissue.  Observing how the quantity of immature 
and/or mature collagen changes over time would be interesting as well.    
After completion of testing using the robotic/UFS testing system, the APTT for the ECM 
+ Mg ring repair group was 37% of that of the sham-operated group.  This was comparable to 
ECM + Mg ring repair at 12 weeks of healing.  Similarly, there were no significant difference 
between the normalized in-situ force of the repaired ACL between ECM + Mg ring repair 
healing at 12 weeks and ECM + Mg ring repair at 26 weeks.  However, it was noticeable that the 
in-situ force decreased significantly at 90° of joint flexion.  There are several possible reasons for 
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the low in-situ force including that the joint functions best at full extension because the repair 
construct is fixed at full extension.  Also, the animals do not undergo any rehabilitation protocol 
and the surrounding structures compensate for the function of the healing ACL.  
The structural properties obtained for ECM + Mg ring repair at 12 weeks and 26 weeks 
had a similar trend.  The normalized ultimate load of the ECM + Mg ring repaired ACL after 12 
weeks was slightly larger than at 26 weeks.  However, it is important to consider the difference 
of the ultimate load of the sham-operated control.  The results suggest that the biomechanical 
evaluation of ECM + Mg ring repair is comparable at 12 weeks and 26 weeks of healing.  These 
findings confirm the hypothesis that the advantages seen at 12 week if healing would persist to 
12 weeks of healing.  Additionally, the failure modes observed from the majority of ECM + Mg 
ring repaired ACLs was at the midsubstance, both at 12 weeks and 26 weeks.  Thus, ECM + Mg 
ring repair can successfully prevent disuse atrophy at the insertion sites. 
The comparisons of ECM + Mg ring repair to previous ACL studies further highlight the 
success of the combined approach.  The structural properties of the reconstructed ACL’s seemed 
to remain constant and increase after 6 months or even up to a year.  ECM + Mg ring repair had 
normalized structural properties better than ACLR which is the gold standard for treatment of 
ACL injuries. 
ECM + Mg ring repair has been successful because of the combined biological and 
mechanical augmentation strategy that attempts to address the challenges of healing the ACL and 
capture the advantages of ligaments that have the innate healing capabilities.  The biological 
augmentation provided by the ECM sheet and bioscaffold is effective because they provide an 
early scaffold for tissue healing, the constructive remodeling of the ECM incite tissue growth 
and the degradation products of the ECM are bioactive as well [253].  Additionally, the ECM 
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sheet provides a temporary synovium that protect the healing tissue.  Since the ECM degrades 
very quickly in vivo, perhaps multiple sheets of ECM would provide a protective barrier longer.  
Future studies of ECM + Mg ring repair could also employ the use of matrix-bound nanovesicles 
[267, 268].  Matrix bound nanovesicles carry proteins and RNA to the region of interest and have 
been shown to regulate the macrophasge phenotype and other cellular responses. 
In addition to the biological augmentation, mechanical augmentation is required to 
support ACL healing.  Indeed, the Mg ring is an integral part of the repair construct.  Since there 
are no bone-to-bone augmentation sutures, the Mg ring helps maintain the stability of the repair 
construct; thus, the mechanical stabilization of the joint at the earlier time points.  As the sutures 
begin to elongate and the Mg ring degrades, the corrosion products from the Mg ring implant 
may also be bioactive for soft tissue healing.  The success of ECM + Mg ring repair is highly 
dependent on the transition of the loading from the repair construct to the healing tissue at an 
appropriate timing where the loading is not pulling weak tissue apart but strengthening healing 
tissue that can endure the loading. 
By protecting the healing tissue, providing bioactive stimulants from the ECM 
bioscaffolds and the Mg implant as well as allowing for helpful loading of the ligament, there are 
some similarities to the healing of the MCL.  While it is hoped, that the strength of the healing 
ACL would improve with time, it seemed to remain similar to that from short-term studies which 
is also seen with MCL healing.  As the MCL heals, there is hypotrophy to accommodate for the 
less quality healing tissue.  Additionally, the MCL has intrinsic healing ability, but doesn’t 
appear to return to the preinjury strength.  Perhaps, that is what is being observed with ACL 
healing from 12 weeks of healing to 26 weeks of healing. 
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Specific Aim 2 demonstrated the ACL healing capacity of ECM + Mg ring repair and 
that it can persist to 26 week of healing.  The healing tissue is characterized by continuous neo-
tissue and the transection site is no longer visible.  The biomechanical outcomes were better than 
ACLR and similar to the short term ECM + Mg ring repair study. 
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6.0  DEVELOPMENT FOR USE IN HUMANS 
6.1 INTRODUCTION 
The use of ECM + Mg ring repair has been shown to successfully heal a transected ACL in a 
goat model.  With these promising results, translation of this healing approach could be designed 
for the human ACL.  Previously, the Mg ring had been designed considering the geometry of the 
goat ACL.  Next, a similar design can be made for the human ACL.  Considering the geometry 
of the human ACL, the Mg ring implant was scaled up and evaluated in a preliminary in vitro 
study of Mg ring repair in cadaveric human knee joints.  Also, a finite element model was 
developed of the Mg ring implanted in the human knee which can be used as a vehicle for future 
design and development of the Mg ring for the human ACL.      
6.2 DESIGN OF MG RING DEVICE FOR HUMAN ACL 
The geometry of the human ACL has been studied for many years (Figure 52).  The ACL is 
characterized as a fan shaped structure with cross section areas and lengths that widely vary 
based on gender and other anatomical factors.  The cross sectional area of human ACL can vary 
between 25 and 60 mm2.  Additionally, the length of the ACL can range between 20 mm and 20 
mm.  Initially, the strategy for designing a Mg ring implant for the human ACL was to scale up 
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the design parameter according to the differences from the goat ACL and the human ACL as 
highlighted in Table 13.  
 
 
Figure 52: Human ACL 
 
Table 13: Relationship between goat ACL and human ACL to scale up Mg ring implant 
 
 
After considering the large range of the dimensions for the human ACL, it was not 
possible to create on device for ACLs of all sizes.  Thus, the ring was redesigned in 3 sizes: 
small, medium, and large (Figure 53 and Table 14).  The design features of the original Mg ring 
implant were maintained including the cylindrical shape with a larger tibial diameter, holes 
through which sutures can pass and notches for stabilizing sutures.  The 3 designs vary by the 
117 
femoral and tibial diameters where the smaller design may be most appropriate for children and 
more petite women and the larger design for men.  
 
 
Figure 53: Mg Ring Design for Human ACL 
 
Table 14: Dimensions for the Mg ring implants designed for Human ACL 
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6.3 IN VITRO EVALUATION OF MG RING REPAIR FOR HUMAN ACL 
6.3.1 Experimental Design 
As a second evaluative method of the Mg ring implant for use in humans, a preliminary in vitro 
study was conducted in cadaveric human knees (N=2).  The Mg ring implant was implanted after 
the same surgery approach from Section 5.2.4.  Then, the robotic/UFS system was used to 
evaluated the Mg ring repair ability to restore joint stability and ligament function.  Afterwards, 
these values were compared to the success of Mg ring repair in the goat model as well as ACL 
reconstruction, the current gold standard treatment for ACL injuries. 
6.3.2 Robotic Testing  
The cadaveric knee joint was thawed at room temperature the day before testing.  Then, it was 
prepared for testing as previously described with the epoxy putty (Everglass, Evercoat, 
Cincinnati, OH).  Then, the specimen was mounted onto the robotic/UFS testing system (Figure 
6).  The path of passive flexion-extension was determined by flexing the joint at 1° increments, 
finding the position that minimizes the resulting forces and moments.  This path provided the 
starting position at each angle of flexion for the application of external loads for the remainder of 
the test and served as the reference position by which to measure knee kinematics.  The knee 
joint was subjected to a (1) 134 N anterior tibial load (2) 134 N anterior tibial load with a 200 N 
compression and (3) 10 NM valgus and 5 NM internal tibial torque (force control).  The resulting 
kinematics including anterior tibial translation (ATT) of the knee joint was measured at 30°, 60°, 
and 90° of joint flexion.  Next, the ACL was transected through its midsubstance using a medial 
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parapatellar incision.  The previously recorded kinematics of the joint with an intact ACL were 
repeated, while the UFS recorded new forces and moments.  The in situ forces of the intact ACL 
were determined in response to the loading condition using the principle of superposition.  
Then, Mg ring repair of the ACL was performed as described in Section 5.2.4.  Once 
complete, the kinematics of the repaired joint were obtained using the loading condition.  
Finally, the ring was removed and the previously recorded kinematics were repeated to obtain in 
situ forces in the Mg ring repaired ACL.  The protocol is detailed in Table 15. 
 
Table 15: Robotic Protocol for Mg ring repair in Human Knee Joint 
 
6.3.3 Data Analysis 
For the in vitro analysis on the cadaveric human knees, APTT and in situ forces in the ACL were 
averaged between specimen.  Two-way ANOVA was used to compare the values of APTT or in 
situ forces in response to the loading condition with the independent factors being joint state 
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(intact, ACL-deficient, or Mg ring repaired) and flexion angle (30°, 60°, 90°). Statistical 
significance will be defined as p<0.05. 
6.3.4 Results 
The ATT of the intact ACL increased between 15° and 60° and decreased at 90° (Figure 
54A).  The ATT of the knee with an intact ACL ranged between 4 mm at 15° to 10 mm at 60° of 
flexion.  After transection of the ACL, the ATT increase as much as 300% and ranged between 
12.6 to 24.3 mm.  After Mg ring repair, the ATT was restored within 4 mm of the intact state 
(Figure 54 B).  The kinematic data of the intact, ACL-deficient, and Mg ring repaired knee joint 
under 134 N anterior tibial load and 134 N anterior tibial load with 200 compression is shown in 
Table 17.  
With the addition of 200 N axial compression to the 134 N anterior tibial load, the 
anterior tibial translation of the intact knee decreased at all flexion angles (Table 16).  For the 
ACL-deficient joint, these values also decreased at 15° and 30° and remained relatively the same 
at 60° and 90°.  After Mg ring repair, the anterior tibial translation was reduced to within 3.5 mm 
of the intact knee. 
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Figure 54: The intact human ACL (A) and the Mg ring repaired human ACL (B) 
 
Table 16: Anterior tibial translation of the intact, ACL-deficient and Mg ring repaired knee joint in response 
to a 134 N anterior tibial load and a 134 N anterior tibial load combined with a 200 N axial compression 
 
 
The magnitude of the in-situ force of the intact ACL decreased from 15° to 90°, ranging 
from 85 N to 170 N under 134 N anterior tibial load (Table 17).  A similar trend was seen with 
the Mg ring repaired ACL, decreasing with an increase in flexion angle of the joint.  With the 
addition of 200 N axial compression, the in situ force of the both the intact and Mg ring repaired 
ACL increased across all angles of joint flexion.   
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Table 17: In-situ force of intact ACL and Mg ring repaired ACL in response to a 134 N anterior tibial load 
and a 134 N anterior tibial load combined with 200 N axial compression 
 
  
Under the combined rotatory load, anterior tibial translation decreased (became more 
negative indicating a posterior direction) from 15° to 30° of knee flexion with all knee conditions 
(Table 198.  After transection of the ACL, the anterior tibial translation increased by up to 2 mm 
compared to intact knee.  After Mg ring repair, anterior tibial translation was within 1 mm of the 
intact joint at both 15° and 30°.  The tibial rotation also increased from 15° to 30° of knee flexion 
(Table 18).  After Mg ring repair, the tibial rotation was within 2 mm of the intact knee.  The 
magnitude of the in-situ force in the ACL under the combined rotatory load decreased from 15° 
to 30° of knee flexion.  This was also seen with the Mg ring repaired ACL (Figure 55). 
 
Table 18: Knee Kinematics of the Intact and Mg ring repaired knee joint in response to a combined 10 Nm 
valgus tibial torque and 5 Nm internal tibial torque 
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Figure 55: Average in-situ force of the intact and Mg ring repaired ACL at 15 and 30 of knee flexion in 
response to a combined 10 Nm valgus and 5 Nm internal tibial torque 
 
In order to evaluate the Mg ring repair of the ACL in the human knee, the joint 
kinematics and in-situ force of the ligament were normalized and compared with previous in 
vitro studies conducted in the goat model and ACLR in human cadaveric knee joints (Figure 56) 
[21, 84].  The normalized ATT of Mg ring repair in the goat model increase from 30° to 90° and 
ranged from 2 to 2.5.  The Mg ring repair in the human knee remained constant across all angles 
of knee flexion at approximately 1.5.  The normalized ATT of the reconstructed ACL using QT 
in human knee ranged from 0.8 to 1.0 and also increased from 30° to 90°. 
124 
 
Figure 56: Normalized anterior tibial translation in response to 134 N anterior tibial load 
 
The normalized in-situ force of the Mg ring repaired ACL in the goat model increased 
from 30° to 90° of knee flexion ranging from 1.0 to 1.2 (Figure 57).  For Mg ring repair in the 
human knee, the normalized in-situ force of the repaired ACL remained constant across all 
angles of knee flexion at approximately 0.8.  These values were closer to the in-situ force of 
intact ACL than the ACL reconstructed with QT having normalized values that increased from 
30° to 90° of knee flexion ranging from 0.6 to 0.8. 
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Figure 57: Normalized in-situ force in response to 134 N anterior tibial load 
6.4 FINITE ELEMENT ANALYSIS 
6.4.1 Model Development 
With the design of the Mg ring implant for the human ACL, finite element analysis (FEA) was 
employed to assess the potential of the implant for ACL healing application.  The FE model 
could be used to confirm that the implant could bridge the gap between the two end of the ACL 
and the repair construct which includes the sutures can load the ACL. 
The FE model used for these simulations was adopted from the OpenKnee project 
(SimTK.org).  This project is a model of the human knee including bones (femur and tibia), 
menisci, and major ligaments (ACL, PCL, LCL, MCL) in addition to layers of articular cartilage.  
With the femur fixed and motion limited in all directions, a 134 N force was applied to the tibia 
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in the anterior direction, boundary and loading conditions adopted from the robotic protocol.  
The resulting kinematics were recorded.  Then, the model was modified to include the femur, 
tibia, transected ACL connected with the Mg ring by sutures (Figure 43).  Then, the recorded 
kinematics were applied to the modified FE model.  The resulting von Mises stress 
concentrations were recorded as an indication of the effectiveness of Mg ring repair in the human 
knee. 
 
 
Figure 58: The finite element model of the Mg ring repaired human knee 
6.4.2 Finite Element Analysis Results 
The von Mises stresses were recorded in the FE model as a result on Mg ring repair.  The 
majority of the stress was seen in the sutures.  There was also evidence of stress on the ACL at 
the contact between the ACL and the sutures as well as in the anterior portion of the 
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midsubstance.  Additionally, there was stress concentrated on the sutures holes of the Mg ring 
implant.  None of the stress values exceeded the yield strength of the structures within the FE 
model.  Future validation and use of the FE model can be used throughout the iterative design 
process of the Mg ring implant for use in humans. 
6.5 DISCUSSION 
With the potential of ECM + Mg ring repair, clinical translation of this healing approach is the 
next logical step.  So, the Mg ring implant device was redesigned for the human ACL.  After 
reviewing literature on the ACL geometry, it was not possible to make one Mg ring implant.  
Therefore, a small, medium, and large implant was designed. 
As we moved forward with in vitro analysis of the Mg ring implant in human cadaver 
knees, we noticed the wide range of ACL sizes.  Using the same sutures and surgical 
implantation as developed for the goat model, the Mg ring was implanted on human cadaver 
ACL.  One of the strengths of the repair construct is the ability to restore joint stability at time 
zero.  This was also demonstrated in the human knee joint even under the 134 N anterior tibial 
load.  The ATT and in-situ force results were superior to ACLR construction studies of similar 
experimental design.   
Finally, the development of a finite element model of the Mg ring implant in the human 
knee has confirmed the loading mechanism of the repair construct. Future validation of the finite 
element model would make it especially useful for future redesign of the Mg ring implant.  
Particularly, the actual design of the implant may need to deviate from the ring shape.  If so, the 
finite element model could be used as an initial assessment tool. 
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7.0  OVERALL DISCUSSION AND CONCLUSIONS 
In this dissertation, further research and development of the ECM + Mg ring repair method was 
pursued.  First, the novel MAO coated single crystal Mg was characterized for corrosion, 
coating, and surface properties.  This was accomplished through in vitro degradation testing and 
measurement of corrosion rate as determined by monitoring the Mg ion concentration, change in 
pH, and change in mass over 4 weeks.  Additionally, the porosity, hardness, roughness, 
hydrophilicity of the coating were measured in order to make assumptions about cell interaction 
with the implant and to establish a benchmark for which further modifications can be based.  
Then, the MAO coated Mg ring implant, made with single crystal Mg, was used to repair a 
transected ACL in a goat model.  The healing was assessed after 26 weeks of healing by 
observing the gross morphology and through extensive biomechanical evaluation to determine 
the joint stability, ligament function, and structural properties of the healed ACL.  Lastly, with 
the exciting results, the Mg ring implant was designed for the human ACL.  Maintaining the 
same design characteristics including suture holes and a larger tibial diameter, three Mg ring 
implants of varying size were designed to account for the wide variation of ACL geometry.  
Then, finite element analysis was used to model the implantation of the Mg ring implant in the 
human knee.  Finally, the Mg ring implant underwent in vitro evaluation in cadaveric human 
knees using the robotic/UFS testing system as an initial step toward clinical translation of the 
ECM + Mg ring repair.   
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7.1 LIMITATIONS  
There several limitations of this dissertation research.  First, the corrosion scenario in real 
biomedical applications is always more complex than in laboratory experiments.  For instance, 
the hydrodynamic condition around the implant surface influences mass transfer.  Consequently, 
the local surface chemistry evolves with time and can be drastically different under static 
conditions.  Thus, dynamic in vitro degradation testing may be more realistic.  However, in vitro 
testing cannot be directly related to in vivo response. 
Secondly, in vivo animal study provides great insight to the healing of the ACL.  
However, the sample size is smaller and there is no control group.  With the challenges and 
expenses associated with large animal studies, we were limited to fewer animals.  Additionally, 
an ACL reconstruction control group would be ideal as ACLR is the current standard of care. 
Thirdly, the goat model cannot be extrapolated to human treatment.  However, extensive 
ACL research has been conducted in the goat model.  Thus, the trends between studies and the 
results of this research provide insight and inspiration for ACL healing.  This research has high 
translational potential as ACL healing would be an advantageous alternative to ACLR. 
Fourthly, the surgical implantation technique in the goat model as well as the preliminary 
study in the human cadaveric knee was an open surgery.  The current standard for knee surgery 
is arthroscopy.  Thus, the implantation technique is not directly translatable.  However, the 
orthopaedic surgeons were able to make the goat surgeries as minimal invasive as possible and 
the goats recovered very well with no adverse effects due to surgical implantation. 
130 
7.2 CONCLUSIONS 
7.2.1 Clinical Implications 
ECM + Mg ring repair is a strategy for healing an injured ACL.  ACL healing is an advantageous 
alternative treatment option to ACLR.  Patients would experience better short and long term 
outcomes, as many of the complications associated with ACLR would be eliminated.  
Furthermore, this would benefit patients, as well s surgeons, hospitals, and insurance companies 
because of reduced time in the operating room as graft harvesting is not required and potentially 
comparable in cost to ACLR.  The successful development of the ACL healing strategy has the 
potential to shift the paradigm of ACL treatment.  Also, this approach could be extended to other 
“hard to heal” ligaments and tendons. 
7.2.2 Scientific/Engineering Significance 
The method of evaluating joint stability and ligament function using the robotic UFS testing 
system is state-of-the art.  The precision provided and the repeatable results is especially 
valuable. The use of advanced protocol and accurate tools allows for efficient comparison of 
treatment options.  Furthermore, development of the finite element model allows for early 
evaluation of implant design and implementation. 
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7.3 FUTURE DIRECTIONS 
The overall goal of this dissertation research was to evaluate the ECM + Mg ring repair of a 
transected ACL and begin efforts toward clinical translation.  In the future, other strategies can 
be evaluated against these results. Since ACL healing is such a complex process, a more multi-
faceted approach to evaluating the healing is advisable (including histology, biomechanics, etc.).  
Finally, continuous modifications to the design and implantation technique are essential.  To 
prepare this approach for human application, it must meet the current standard of care which is 
arthroscopy. 
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